5 March 2018
Market snapshot
Equities - India
Close
Chg .%
Sensex
34,047
-0.4
Nifty-50
10,458
-0.3
Nifty-M 100
19,512
-0.8
Equities-Global
Close
Chg .%
S&P 500
2,691
0.5
Nasdaq
7,258
1.1
FTSE 100
7,070
-1.5
DAX
11,914
-2.3
Hang Seng
12,204
-1.8
Nikkei 225
21,182
-2.5
Commodities
Close
Chg .%
Brent (US$/Bbl)
64
-0.7
Gold ($/OZ)
1,317
-0.1
Cu (US$/MT)
6,864
-0.3
Almn (US$/MT)
2,139
-0.6
Currency
Close
Chg .%
USD/INR
65.2
0.0
USD/EUR
1.2
0.6
USD/JPY
106.2
-0.4
YIELD (%)
Close
1MChg
10 Yrs G-Sec
7.7
0.01
10 Yrs AAA Corp
8.4
0.00
Flows (USD b)
1-Mar
MTD
FIIs
0.0
-1.9
DIIs
0.0
2.8
Volumes (INRb)
1-Mar
MTD*
Cash
319
377
F&O
13,186
8,673
Note: YTD is calendar year, *Avg
YTD.%
0.0
-0.7
-7.7
YTD.%
0.7
5.1
-8.0
-7.8
4.2
-7.0
YTD.%
-4.2
1.1
-4.8
-5.2
YTD.%
2.0
2.2
-5.7
YTDchg
0.4
0.5
YTD
0.1
2.8
YTD*
403
7,942
Today’s top research idea
HDFC Bank: The juggernaut
HDFC Bank has consistently grown its market share in loans and deposits across
credit cycles, and has emerged as the best-managed bank in India with robust
profitability/growth metrics. Increasing granularity of the balance sheet, a
focus on fee income growth, an improvement in operating leverage aided by
digital initiatives, and controlled credit costs backed by strong underwriting
have enabled the bank to outperform most peers.
We expect the bank to maintain its growth momentum and further gain market
share across business segments. This, coupled with steady revenue growth, a
continued improvement in operating leverage and moderation in credit cost,
will help accelerate earnings growth (24% CAGR over FY18-20E).
We expect HDFCBK to deliver RoA/RoE of 1.96%/17.4% in FY20E. We maintain
our Buy rating with a target price of INR2,400.
Research covered
Cos/Sector
HDFC Bank
Automobile
Laurus Labs
Rain Industries
Fortis Healthcare
Key Highlights
The juggernaut
FEB-18 Volumes Nos: 1. Maruti Suzuki; 2. Tata Motors; 3. Bajaj Auto
USFDA compliance intact; Approval to start US sales
Carbon prices and margins continue to improve
2Q in-line, but a miss in 3Q; Entry of third-party key for re-rating
Piping hot news
Proxy advisory firm questions exemptions in Rs 369-bn ONGC-HPCL deal
Proxy advisory firm IiAS has questioned state-owned ONGC seeking exemption
from taking shareholders' nod for acquisition of the government's stake in HPCL,
saying such leniency with regard to public votes is not warranted. …
Chart of the Day: HDFC Bank – The juggernaut
RoRWA has increased at the same pace as RoA
PPoP to RWA has held strong even in periods of RoRWA
decline
Source: MOSL, Company
Source: MOSL, Company
Research Team (Gautam.Duggad@MotilalOswal.com)
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.

In the news today
Kindly click on textbox for the detailed news link
1
PNB scam: NCLT bars 64 firms
from selling assets
The National Company Law
Tribunal (NCLT) has restrained
over 60 companies, including
those belonging to Rs 12,600-
crore PNB fraud accused Nirav
Modi and his uncle Mehul Choksi,
from selling their assets, according
to a government announcement
on Sunday. The ex-parte NCLT …
2
India set to beat Japan in steel output, become second largest
producer
At the Third position in steel output over the last three years, India is
within striking distance of dislodging Japan as the second largest producer
of steel. However, the jump would still leave it far behind China which,
with 831.7 MT, accounted for 49.2% of the global output of 1,692 MT in
2017. The gap in production between Japan and India was almost reduced
to naught in the first month of the current year. This followed a consistent
pattern since 2013 when Japan’s output of 100.5 MT of steel was a good
29 MT higher than India’s.
3
Five PSBs on brink of being put
under RBI's prompt corrective
action plan
Five public sector banks (PSBs),
including Canara and Union Bank
of India, are on the brink of being
put under the Reserve Bank of
India’s (RBI’s) prompt corrective
action (PCA) plan. According to
rating agency Icra, their net non-
performing assets (NPAs) rose
above 6 per cent in December
2017. If the banking regulator …
4
Media and entertainment
sector seen growing at 11.6%
to Rs2 trillion by 2020
The Indian media and
entertainment (M&E) industry is
expected to grow at an annual
average rate of 11.6% to reach Rs2
trillion by the year 2020. The M&E
sector reached about Rs1.5 trillion
in 2017, a growth of around 13%
over 2016, said a report released
by the lobby group Federation of
Indian Chambers of Commerce …
5
SBI tightens project finance,
not to fund interest payments
State Bank of India has decided
against funding interest during
construction, a move that could
spell further trouble for
companies seeking project
finance from the nation’s largest
lender as they cannot keep
interest payment pending until
projects start generating
revenue. The decision is aimed at
de-risking the bank’s loan …
6
Dues to sugarcane farmers
soar to Rs14,000 crore
Following higher sugar production
and plummeting wholesale prices,
dues to sugarcane farmers from
mills are piling up, shows latest
numbers. According to the Indian
Sugar Mills Association (ISMA), till
January end, sugar mills across
various states owed farmers
Rs13,932 crore. Payment to cane
growers is considered ‘due’ when it
is delayed by more than 14 days …
7
Adani Gas plans direct listing
of shares
Adani Gas Ltd, the gas
distribution business of Adani
Group, is planning to go for a
direct listing of shares instead of
an initial public offering, two
people aware of the
development said. In January,
the Adani Group decided to
demerge its gas sourcing and
distribution business into a new
company called Adani Gas Ltd.
The board of Adani Enterprises…
5 March 2018
2

HDFC Bank
BSE SENSEX
34,047
S&P CNX
10,458
1 March 2018
Update | Sector: Financials
CMP: INR1,872
The juggernaut
TP: INR2,400(+28%)
Buy
Stock Info
Bloomberg
Equity Shares (m)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
M.Cap. (INR b)
M.Cap. (USD b)
Avg Val, INRm
Free float (%)
HDFCB IN
2,563
2014 / 1369
0/-1/18
5,023
77.9
3318.0
79.0
Financials Snapshot (INR b)
2018E 2019E 2020E
Y/E Mar
NII
409.5 484.7 588.8
OP
328.9 395.5 490.2
NP
175.8 216.4 270.9
NIM (%)
4.6
4.5
4.5
EPS (INR)
67.0
80.6 100.9
EPS Gr. (%)
18.0
20.3
25.2
BV/Sh. (INR)
473.8 538.2 621.0
ABV/Sh. (INR)
450.0 511.9 591.6
RoE (%)
16.2
15.9
17.4
RoA (%)
1.8
1.9
2.0
Payout (%)
21.1
20.2
17.9
Valuations
P/E(X)
27.9
23.2
18.6
P/BV (X)
4.0
3.5
3.0
P/ABV (X)
4.2
3.7
3.2
Div. Yield (%)
0.8
0.9
1.0
Shareholding pattern (%)
As On
Dec-17 Sep-17 Dec-16
Promoter
21.0
21.0
21.3
DII
12.2
11.6
12.4
FII
51.4
52.2
50.5
Others
15.4
15.1
15.9
FII Includes depository receipts
Stock Performance (1-year)
HDFC Bank
Sensex - Rebased
2,200
2,000
1,800
1,600
1,400
1,200
HDFC Bank (HDFCBK) has consistently grown its market share in loans and deposits across
credit cycles, and has emerged as the best-managed bank in India with robust
profitability/growth metrics. Increasing granularity of the balance sheet, a focus on fee
income growth, an improvement in operating leverage aided by digital initiatives, and
controlled credit costs backed by strong underwriting have enabled the bank to
outperform most peers. We expect the bank to maintain its growth momentum
(regardless of its systemic size) and further gain market share across business segments.
This, coupled with steady revenue growth, a continued improvement in operating
leverage and moderation in credit cost, will help accelerate earnings growth (24% CAGR
over FY18-20E). Moreover, its subsidiaries – HDB Financial Services and HDFC Securities –
are rapidly gaining scale and will further support valuations. We expect HDFCBK to
deliver RoA/RoE of 1.96%/17.4% in FY20E (RoE is suppressed as we have built in capital
raise of INR240b). We maintain our Buy rating with a target price of INR2,400.
Market share gains to continue; No size too big
Over the past 10 years, HDFCBK has steadily grown its loans/deposits market share
to ~7.8%/ 6.4% of the system, driven by steady branch addition (up 7x from 684 in
FY07 to 4,715 in FY17), improving employee productivity (business/employee
doubled over FY07-17), and effective use of technology to gain distribution
efficiency (cost-to-core income ratio decreased 840bp to 44.5% over FY07-17). The
bank has also recorded the highest incremental market share among peers. We
expect HDFCBK to continue gaining market share to reach 10% by FY22, driven by
robust growth in the vehicle portfolio, business banking and unsecured segments.
Retail loan growth remains strong; working diligently to expand the pie
HDFCBK has grown its retail book at a 27% CAGR over the past three years,
significantly ahead of systemic retail loan growth. Enhanced focus on rural and
semi-urban locations has helped the bank to gain strong traction in retail and SME
loans. SME loan growth has also received a boost from digitization of the
application process, which has reduced the turnaround time (TAT). While the share
of unsecured personal and credit card loans has increased, the bank’s credit
monitoring framework remains robust, helping it maintain strong control on
delinquency levels. The bank has 50%+ market share in the credit card business; it
targets to double its outstanding card base over the next three years.
Robust third-party and bancassurance fees are driving overall fee growth
HDFCBK has built a strong and well-diversified fee income profile over the years.
While fee income forms ~1.2% of average assets and ~23% of total income, the
contribution of third-party distribution to total fees has steadily increased to 16%
from 11% in FY14. This was driven by a 14% CAGR in third-party fees over FY12-17.
Bancassurance income from HDFC Standard Life Insurance forms ~32% of HDFCBK’s
third-party distribution fees. HDFCBK continues to command >70% of total
3
5 March 2018

commissions paid by HDFC Life, which, coupled with strong new business growth
trend for HDFC Life (43% growth over FY18YTD), provides visibility of robust fee
income from this channel.
Operating leverage continues to surprise positively; digital initiatives help
reduce sourcing costs
The bank has channelled its digital abilities to reduce involvement of manpower in
routine, process-driven operations, with an aim to enable employees to focus more
on business generation. Initiatives such as 10-second personal loans and pre-
approved auto loans have helped reduce sourcing costs, leading to a steady
improvement in cost-ratios. Over the past four years, the C/I ratio has improved by
450bp to 41%, and the cost-asset ratio by 31bp to 2.4%. We expect continued
operating leverage improvement (38.4% cost-income by FY20E), led by (i) controlled
employee/network growth, (ii) further improvement in branch productivity and (iii)
lower operating expenses due to increasing usage of technology.
Subsidiaries rapidly gaining scale; expected to add ~4.3% to valuations
Both HDB Financials and HDFC Securities have grown robustly over the last three
years. While HDB Financials reached AUM of INR352b by 1QFY18 (comparable to
CIFC), HDFC Securities recorded ~40% PAT CAGR over FY14-17, with its RoE
improving to a healthy level of 29%+ from 22% in FY16. We expect both the
subsidiaries to maintain strong growth trajectory over the next few years. At 25x
FY20E earnings for HDFC Securities and 3.5x FY20E BV for HDB Financials, the two
subsidiaries together would add INR103 to our TP, post hold-co discount of 20%.
Improvement in RoRWA underscores adequate pricing of risk; asset quality
risks well in control
Owing to stronger growth in the unsecured portfolio, the bank’s RWA has steadily
increased to 79% of total assets, indicating an increase in the risk profile. However,
we note that besides the improvement in RoA (40bp improvement over FY11-18),
the RoRWA of the bank has improved by ~30bp to ~2.5% during the same period.
This indicates that – (i) profitability has improved on the back of multiple levers
(higher fee income and lower opex) rather than simply taking on higher balance
sheet risk and (ii) the bank is able to adequately price the incremental risk it is taking
via robust growth in the unsecured portfolio. The delinquency trend in the
unsecured portfolio also remains well in control, given that >60% of credit card
loans and >50% of personal loans are disbursed to existing customers with a strong
credit history. HDFCBK’s focus in extending these products largely to salaried
customers also helps it in maintaining healthy asset quality.
Valuation view
We expect HDFCBK to record 23% loan book CAGR and 24% PAT CAGR over FY18-
20E, with RoA/RoE of 1.96%/17.4% in FY20E (RoE is suppressed as we have built in
capital raise of INR240b in our numbers). While margins may contract slightly due to
intensifying competition, its robust fee income profile and strong control on
operating leverage will continue driving a steady improvement in the return ratios
(12bp improvement in RoA over FY18-20E). We arrive at a target price of INR2,400
(3.9x Mar’20E ABV and INR103 for subs) and maintain our
Buy
rating.
5 March 2018
4

Sector Update| 1 March 2018
Automobiles
Maruti Suzuki
CMP: INR8,876
Stock Info
Bloomberg
Equity Shares (m)
M.Cap. (INR b)/(USD b)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
TP: INR10,972 (+24%)
Buy
MSIL IN
302
Domestic sales grew by 14.2% YoY and exports by 24.9% YoY
2,025/31.6
7249 / 3868
MSIL’s Feb-18 wholesales came in line at 149.8k units (+15% YoY, -1% MoM). YTDFY18
5/22/55
Dispatches up 15% YoY to 149.8k units (in-line)
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Sales
795.7 956.4 1,114.7
EBITDA
124.0 158.3 196.4
Adj. PAT
81.6 109.9 140.4
Adj. EPS (INR)* 275.6 369.9 471.3
EPS Gr. (%)
10.8 34.2
27.4
BV/Sh. (INR) 1,365 1,597 1,899
RoE (%)
19.8 22.8
24.5
RoCE (%)
27.8 31.7
33.8
Valuations
P/E (x)
32.2 24.0
18.8
EV/EBITDA (x) 19.1 14.5
11.2
Div. Yield (%)
1.0
1.2
1.5
*Cons.
growth was at 13.2%, with a residual monthly run-rate of 164.7k units.
Domestic volumes grew 14.2% YoY to 137.9k (est. of 143.8k), led by continued growth
in the compact (+31.5% YoY) and UV (+13.8% YoY) segments.
Growth in the compact segment was led by new Swift, Baleno and new Dzire, while
that in UVs was led by Brezza and new S-cross.
Ciaz sales declined 16.8% YoY to 4.9k units (est. of 5.1k units).
Export volumes were better than estimate at 11.9k units (+24.9% YoY, +10.9% MoM).
The stock trades at 24x/18.8x FY19E/20E earnings. Maintain Buy.
Snapshot of volumes for Feb-18
YoY
Company Sales
Maruti Suzuki
LCVs
Vans
Mini Segment
Compact (incl Dzire
Tour)
Mid Size - CIAZ
UVs
Total Domestic
Export
YoY (%)
chg
149,824 130,280 15.0
1,252
136
12,425 14,195 -12.5
33,789 33,079
2.1
Feb-18 Feb-17
65,213 49,576
31.5
MoM
Residual Residual FY18 YTD
Growth Monthly Monthly
MoM
(%)
FY18
Jan-18
FY18YTD FY17YTD
Gr. (%)
(%) Run rate Run rate
(%) chg
chg estimate
151,351 -1.0 1,618,976 1,428,840 13.3 1,783,710
13.7
17.9 164,734 147,180
1,411 -11.3
8,621
596
8,500
-121
784
12,250
1.4 141,448 140,381 0.8
160,282
5.4
62.0 18,834 12,859
33,316
1.4 389,672 383,008 1.7
426,400
3.0
18.6 36,728 35,425
67,868
-3.9
679,590
555,597 22.3
750,428
28.3
-8.0
30.8
15.0
-1.0
142.2
70,838
61,781
4,897 5,886 -16.8
5,062
20,324 17,863 13.8 20,693
137,900 120,735 14.2 140,600
11,924 9,545 24.9 10,751
-3.3
54,592
59,530 -8.3
59,292
-1.8 230,995 177,430 30.2
255,983
-1.9 1,504,918 1,316,542 14.3 1,660,886
10.9 114,058 112,298 1.6
122,824
-4.4
4,700
4,963
36.5 24,988 21,000
21.9 155,968 136,811
-25.5
8,766 10,369
5 March 2018
5

Tata Motors
CMP: INR371
Stock Info
Bloomberg
Equity Shares (m)
M.Cap.(INR b)/ (USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
TTMT IN
3395.9
1525/22.8
599 / 376
-4/-21/-7
TP: INR515 (+39%)
Buy
Wholesales of 63.8k units in line with estimate of 64.3k
CV sales grew 30.7% YoY to 45.9k units (in-line)
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Net Sales
2,970 3,354 3,576
EBITDA
375.0 528.4 554.5
NP
94.9 196.6 198.7
Adj. EPS (INR) 28.0 57.9
58.5
EPS Gr. (%)
41.1 107.1
1.1
BV/Sh. (INR) 208.9 268.1 327.8
RoE (%)
14.7 24.3
19.6
RoCE (%)
8.1 12.8
10.7
Valuations
P/E (x)
13.3
6.4
6.3
P/BV (x)
1.8
1.4
1.1
EV/EBITDA (x)
4.0
2.8
2.5
Tata Motors’ Feb-18 sales grew 34% YoY to 63.8k units (in line with est. of 64.3k units).
PV sales increased 43.3% YoY, as car segment volumes grew 16.8% YoY and UV
segment volumes rose 153% YoY due to healthy demand of Nexon.
Total CV volumes increased 30.7% YoY to 45.9k units (in-line), led by an increase in
both LCV and HCV sales by 39.5% and 22.1%, respectively.
The stock trades at 6.4x/6.3x FY19E/20E consol. EPS. Maintain Buy.
Snapshot of volumes for Feb-18
Company Sales
Tata Motors
HCV's
LCV's
CV's
Cars
UV's
Feb-18
63,761
21,594
24,308
45,902
11,728
6,131
Residual Residual FY18 YTD
MoM
Growth Monthly Monthly
YoY
MoM
FY18
Feb-17
Jan-18
FY18YTD FY17YTD (%) chg
Gr. (%)
(%)
Run rate Run rate
(%) chg
(%) chg
estimate
47,573 34.0 64,712 -1.5 562,874 485,177 16.0 631,568 16.5
20.2 68,694 51,170
17,681 22.1 18,612 16.0 167,431 155,315 7.8 185,844
5.7
-10.4 18,413 15,221
17,426 39.5 25,774 -5.7 225,884 188,280 20.0 252,430 20.8
28.2 26,546 20,535
35,107 30.7 44,386 3.4 393,315 343,595 14.5 438,274 13.9
9.0 44,959 35,756
10,042 16.8 13,535 -13.4 124,688 123,738 0.8 141,384
3.2
25.7 16,696 11,335
2,424 152.9 6,791 -9.7
44,871 17,844 151.5
51,910 153.9
170.6
7,039
4,079
YoY
5 March 2018
6

Bajaj Auto
CMP: INR3,025
Bloomberg
Equity Shares (m)
M.Cap. (INR b) / (USD b)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Financial & Valuation (INR b)
Y/E MARCH 2018E 2019E
Sales
249
277
EBITDA
47.3 55.5
Consol. NP
43.5 50.4
ConsEPS(INR) 150
174
EPS Gr. (%)
6.5 15.8
BV/Sh. (INR)
651
725
RoE (%)
24.2 25.3
RoCE (%)
22.0 23.1
Payout (%)
52.0 51.8
Valuation
P/E (x)
20.1 17.4
P/BV (x)
4.6
4.2
EV/EBITDA (x) 15.3 12.7
Div. Yield (%)
2.1
2.5
BJAUT IN
289.4
840.6/13.1
3122/2366
2/-6/0
TP: INR4,031 (+33%)
Buy
Feb-18 dispatches at 357.9k units (est. of 344k); +30.8% YoY
Domestic volumes up 34.5% YoY to 214k units (above est. of 198.5k)
BJAUT’s Feb-18 sales increased 30.8% YoY to 357.9k units (est. of 344k units).
Domestic volume increased 34.5% YoY to 214k (est. of 198.5k), while exports rose
25.7% YoY to 143.9k (est. of 145.5k).
Overall motorcycle volumes increased 21.5% YoY. Domestic motorcycle dispatches
increased ~23% YoY to 175.5k units. Motorcycle exports grew ~19% YoY to 122k units.
3W volumes remained strong, increasing 111% YoY overall. Domestic 3W volume
continued its positive trajectory, with growth of 129% YoY to 38.5k units. 3W exports
rose 86% YoY to 21.8k units.
Speaking on monthly volume, Mr S Ravikumar, President, Business Development said,
“As far as domestic motorcycle is concerned, there has been a cause of worry for us a
couple of months back. Now with the Discover twins that have been launched, in the
month of February itself, we have built-out almost about some 27k units in domestic
and with Avengers refreshed and the Cruise 220 is taking the market very nicely,
people are liking it a lot and there again the numbers are kicking in”.
The stock trades at 17.4x/15x FY19E/20E consol. EPS. Maintain Buy.
2020E
314
64.4
58.3
202
15.8
814
26.2
33.3
50.7
15.0
3.7
10.6
2.8
Snapshot of volumes for Feb-18
YoY
Company Sales
Bajaj Auto
Motorcycles
Total Two-Wheelers
Three-Wheelers
Domestic
Exports
Feb-18 Feb-17
357,883
297,514
297,514
60,369
214,023
143,860
YoY (%)
chg
273,513 30.8
244,958 21.5
244,958 21.5
28,555 111.4
159,109 34.5
114,404 25.7
MoM
MoM
Jan-18
(%) chg
353,147
1.3
288,936
3.0
288,936
3.0
64,211 -6.0
202,193
5.9
150,954 -4.7
FY18YTD FY17YTD
3,672,443 3,393,667
3,099,395 2,975,697
3,099,395 2,975,697
573,048 417,970
2,140,614 2,085,338
1,531,829 1,308,329
(%)
chg
8.2
4.2
4.2
37.1
2.7
17.1
Residual Residual FY18 YTD
Growth Monthly Monthly
FY18
Gr. (%)
(%) Run rate Run rate
estimate
3,989,803
8.8
16.6 317,360 333,858
3,359,709
4.3
6.6 260,314 281,763
3,359,709
4.3
6.6 260,314 281,763
630,094 41.3
103.4 57,046 52,095
2,330,249
3
12.0 189,635 194,601
1,659,555 17.6
24.0 127,726 139,257
5 March 2018
7

Mahindra & Mahindra
CMP: INR733
Stock Info
Bloomberg
Equity Shares (m)
M.Cap.(INR b)/(USD b)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
MM IN
592.6
794.7/12.4
1509 / 1142
3/6/-10
TP: INR884 (+21%)
Buy
Wholesales of 71.6k units above estimate of 66.3k units
UV volume up 16.2% YoY; Tractor volume up 36.5% YoY
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Sales
470.9 531.0 589.0
EBITDA
58.4 66.8
75.5
NP*
41.3 46.2
52.5
Adj.EPS(INR)* 34.8 38.9
44.2
EPS Gr. (%)
10.3 12.1
13.5
Cons.EPS(INR) 37.7 43.9
48.4
BV/Sh. (INR)
241
268
300
RoE (%)
14.4 14.4
14.7
RoCE (%)
13.2 13.5
13.8
Valuations
P/E (x)
21.1 18.8
16.6
P/BV (x)
3.0
2.7
2.4
EV/EBITDA (x) 14.4 12.4
9.4
*incl. MVML
MM’s volumes grew 23.8% YoY to 71.6k units (est. of 66.3k units), as all segments
reported growth during the month.
Tractors sales increased 36.5% YoY to 20.5k units (est. of 18k units), as domestic and
export volumes increased 39% and 3%, respectively.
UV sales (incl. pick-ups) stood at 44.3k units (+16.2% YoY), above estimate of 42k
units.
Momentum in pick-ups continued with 27.4% YoY growth, while passenger utility
vehicles reported growth of 7.4% YoY.
LCV (>3.5t) sales grew by ~56% YoY and M&HCV sales by 16% YoY.
3W volumes increased ~50% YoY to 5.1k units (est. of 4.5k units).
Speaking on the monthly performance, Rajan Wadhera, President, Automotive Sector,
M&M Ltd. said, “We are happy with our February performance with the business
having registered a growth of 19%. This performance comes on the back of a sustained
momentum and demand, both in the personal and commercial vehicle segments,
which we believe will also continue in the month of March.”
Rajesh Jejurikar, President - Farm Equipment Sector, Mahindra & Mahindra Ltd. said,
“We have sold 19,280 tractors during February 2018 with a growth of 39% over last
year. With the announcement of record horticulture production and increased Union
budget allocations to rural and agriculture sector, we expect the growth momentum
to continue in the coming months. In the exports market, we have sold 1,203 tractors
during the month."
The stock trades at 18.8x/16.6x FY19E/20E. Maintain Buy.
Snapshot of volumes for Feb-18
YoY
Company Sales
Feb-18 Feb-17
YoY
(%) chg
57,833 23.8
38,111 16.2
1,289 33.5
3,426 50.0
15,007 36.5
MoM
MoM
Jan-18
(%) chg
73,923
-3.1
45,611
-2.9
1,693
1.7
4,744
8.3
21,875
-6.4
FY18YTD FY17YTD
775,694 694,547
423,784 391,879
14,781 11,769
48,023 47,244
289,106 243,655
(%)
chg
11.7
8.1
25.6
1.6
18.7
Residual Residual FY18 YTD
Growth Monthly Monthly
FY18
Gr. (%)
(%) Run rate Run rate
estimate
834,430 17.9
346.9 58,736 70,518
461,454
5.5
-17.2 37,670 38,526
16,660 16.2
-26.9
1,879
1,344
53,875
3.0
15.6
5,852
4,366
302,441 15.0
-31.0 13,335 26,282
Mahindra & Mahindra 71,610
UV (incl. pick-ups)
44,268
LCV
1,721
Three-Wheelers
5,138
Tractors
20,483
5 March 2018
8

EICHER Motors
CMP: INR27,735
Stock Info
Bloomberg
EIM IN
Equity Shares (m)
27.2
M.Cap.(INR b)/(USD b)
644.0/9.6
52-Week Range (INR) 29983/18006
1, 6, 12 Rel. Per (%)
6/8/37
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Net Income
89.4 107.7 129.5
EBITDA
28.4
35.3
44.1
Net Profit
22.6
28.7
36.3
Adj. EPS (INR) 829.4 1,053.0 1,335.0
EPS Gr. (%)
34.5
27.0
26.8
BV/Sh. (INR) 2,613 3,465 4,570
RoE (%)
36.2
34.6
33.2
RoCE (%)
31.7
30.9
30.7
Payout (%)
0.5
0.6
0.7
Valuations
P/E (x)
33.4
26.3
20.8
P/BV (x)
10.6
8.0
6.1
EV/EBITDA (x) 21.1
16.5
12.9
TP: INR34,764 (+25%)
Buy
RE, VECV Feb-18 dispatches in line
RE volume grew 25% YoY to 73.1k units; VECV volume up 26% YoY to 6.8k
units
RE Feb-18 volume was in line at 73.1k units (+25% YoY).
RE exports of 1.7k units were flat YoY.
VECV's volumes increased 26.3% YoY to 6.8k units (in-line).
Domestic LMD and HD segments grew 40.3% YoY and 13.9% YoY, respectively. Buses
volume declined 22.3% YoY.
VECV exports grew ~84% YoY to 1,013 units (est. of 750 units).
The stock trades at 26.3x/20.8x FY19E/20E consol. EPS. Maintain Buy.
Snapshot of volumes for Feb-18
Company Sales
Eicher Motors
Royal Enfield
VECV
Domestic LMD
Domestic HD
Domestic Buses
Total Domestic
Exports
MoM
YoY (%)
(%)
MoM
Feb-18 Feb-17
Jan-18
FY18YTD FY17YTD
chg
chg
(%) chg
73,077
6,796
3,594
1,345
844
5,783
1,013
58,439 25.0
5,379 26.3
2,561 40.3
1,181 13.9
1,086 -22.3
4,828 19.8
551 83.8
77,878
6,712
3,717
1,371
922
6,010
702
-6.2
1.3
-3.3
-1.9
-8.5
-3.8
44.3
744,406 606,377 22.8
55,628 50,353 10.5
28,559 23,080 23.7
10,292
9,463 8.8
9,041 10,453 -13.5
47,892 42,996 11.4
7,736
7,357 5.2
YoY
Residual Residual FY18 YTD
Growth Monthly Monthly
FY18
Gr. (%)
(%) Run rate Run rate
estimate
821,629
64,948
32,395
11,553
11,345
55,293
8,492
23.3
11.0
24.5
4.0
-7.5
9.3
5.7
28.5
14.2
30.2
-23.4
26.8
-2.3
11.5
77,223
9,320
3,836
1,261
2,304
7,401
756
67,673
5,057
2,596
936
822
4,354
703
5 March 2018
9

Hero MotoCorp
CMP: INR3,579
Stock Info
Bloomberg
Equity Shares (m)
M.Cap.(INR b)/ (USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
HMCL IN
199.7
635/9.5
3813 / 2844
9/-1/4
TP: INR3,986 (+11%)
Neutral
Vols up 20% YoY to 629.6k (above est. of 602.5k)
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Sales
318.4 351.9 385.4
EBITDA
52.7 56.3
60.3
NP
36.9 40.0
42.6
Adj. EPS (INR) 185.0 200.1 212.6
EPS Gr. (%)
9.4
8.2
6.2
BV/Sh. (INR) 582.8 668.5 752.9
RoE (%)
34.0 32.0
29.9
RoCE (%)
32.8 31.0
29.1
Valuations
P/E (x)
19.4 17.9
16.8
P/BV (x)
6.1
5.4
4.8
EV/EBITDA (x) 12.1 11.1
10.3
Div. Yield (%)
2.5
2.7
2.9
HMCL’s Feb-18 volumes of 629,597 units (+20% YoY) were above our estimates of
602.5k units.
The company showcased its premium motorcycle ‘XPulse’ and its new range of 125cc
scooters ‘Maestro Edge 125’ and ‘Duet 125’ at Auto Expo 2018. It had also unveiled its
premium motorcycle ‘Xtreme 200R’ recently. These products would be available in the
market over the next few months.
HMCL trades at 17.9/16.8x FY19E/20E EPS. Maintain Neutral.
Snapshot of volumes for Feb-18
Company Sales
Hero MotoCorp
MoM
Residual Residual FY18 YTD
Growth Monthly Monthly
YoY (%)
(%)
FY18
MoM
Feb-18 Feb-17
FY18YTD FY17YTD
Jan-18
Gr. (%)
(%) Run rate Run rate
chg
chg estimate
(%) chg
629,597 524,766 20.0 641,501 -1.9 6,852,384 6,053,952 13.2 7,505,752 12.6
7.1 653,368 622,944
YoY
5 March 2018
10

Ashok Leyland
CMP: INR141
Stock Info
Bloomberg
Equity Shares (m)
M.Cap.(INR b)/ (USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
AL IN
2,845.9
254.0/3.8
112 / 74
3/3/-29
TP: INR158 (+12%)
Buy
Dispatches in line at 18.2k units
MHCVs grew 21.2% YoY, while LCVs rose 62.7% YoY
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Sales
251.7 288.7 330.0
EBITDA
26.0 31.3
36.1
NP
14.4 18.2
22.6
Adj. EPS (INR)
4.9
6.2
7.7
EPS Gr. (%)
16.2 26.7
24.0
BV/Sh. (INR)
23.4 26.9
31.6
RoE (%)
22.1 24.7
26.4
RoCE (%)
18.6 20.9
22.7
Valuations
P/E (x)
28.7 22.6
18.3
P/BV (x)
6.0
5.2
4.5
EV/EBITDA (x) 15.4 12.3
10.2
Div. Yield (%)
1.4
1.6
1.8
AL’s Feb-18 wholesale dispatches were in-line at 18.2k units (+29.2% YoY).
M&HCV volumes, which account for 75% of total volumes, grew 21.2% YoY (+0.6%
MoM) to 13.7k units (est. of 13.5k units).
LCVs (Dost) grew 62.7% YoY to 4.5k units (est. of 4.4k).
The stock trades at 22.6x/18.3x FY19E/20E EPS, and at 12.3x/10.2x EV/EBITDA.
Maintain Buy.
Snapshot of volumes for Feb-18
YoY
Company Sales
Ashok Leyland
CV (ex LCV)
LCV
Feb-18
18,181
13,726
4,455
Feb-17
YoY (%)
chg
14,067 29.2
11,329 21.2
2,738 62.7
MoM
Residual Residual FY18 YTD
Growth Monthly Monthly
(%)
FY18
MoM
FY18YTD FY17YTD
Gr. (%)
Jan-18
(%) Run rate Run rate
chg estimate
(%) chg
18,101
0.4 152,378 126,383 20.6
170,394 17.5
-3.6 18,016 13,853
13,643
0.6 114,333 98,037 16.6
127,904 12.9
-11.0 13,571 10,394
4,458
-0.1
38,045 28,346 34
42,490 33.7
29.7
4,445
3,459
5 March 2018
11

TVS Motor
CMP: INR 677
Stock Info
Bloomberg
Equity Shares (m)
M.Cap.(INR b)/ (USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
TP: INR741 (10%)
Neutral
TVSL IN
475.1
Domestic sales grew by 34% YoY, exports up 53.2% YoY
235.5/3.7
549 / 280
Wholesales of 290.7k units (+37.5% YoY) were above estimate of 272k.
4/31/69
Feb-18 wholesales up 37.5% YoY to 290.7k units
Financials Snapshot (INR b)
Y/E MARCH 2018E 2019E 2020E
Sales
150.5 187.9 225.4
EBITDA
11.7 19.1
24.9
Adj. PAT
6.6 11.9
16.1
EPS (INR)
13.9 25.1
33.9
EPS Gr. (%)
18.5 80.5
34.9
BV/Sh (INR)
61.0 81.3 109.2
RoE (%)
24.9 35.3
35.6
RoCE (%)
25.4 37.9
42.1
Payout (%)
25.9 19.1
17.7
Valuations
P/E (x)
48.6 26.9
20.0
P/BV (x)
11.1
8.3
6.2
EV/EBITDA (x) 28.4 17.1
12.7
Div. Yield (%)
0.4
0.6
0.7
Domestic volumes grew 34% YoY, while exports (20% of volumes) rose 53.2% YoY.
Motorcycle volumes grew 92% YoY to 113.3k units (est. of 95k units).
Scooter volumes increased 35.6% YoY to 93.6k units (est. of 87k units).
Moped dispatches declined 5.3% YoY to 74.1k units (est. of 81k).
3W volumes increased 86.3% YoY, with growth across domestic and export sales.
Total exports grew 53.2% YoY, led by growth in 2W and 3W exports.
The stock trades at 26.9x/20x FY19E/20E EPS. Maintain Neutral.
Snapshot of volumes for Feb-18
YoY
Company Sales
TVS Motor
Motorcycles
Scooters
Mopeds
Three-Wheelers
Total Domestic
Total Exports
Feb-18
290,673
113,296
93,573
74,073
9,731
232,109
58,564
Feb-17
YoY
(%) chg
211,470 37.5
58,994 92.0
69,020 35.6
78,233 -5.3
5,223 86.3
173,255 34.0
38,215 53.2
MoM
Residual Residual FY18 YTD
Growth Monthly Monthly
FY18
MoM
Jan-18
FY18YTD FY17YTD (%) chg
Gr. (%)
(%) Run rate Run rate
estimate
(%) chg
271,801 6.9 3,139,451 2,667,617 17.7 3,450,117 18.0
21.8 310,666 285,405
98,649 14.8 1,221,164 981,415 24.4 1,341,918 25.1
32.6 120,754 111,015
85,521 9.4 1,033,946 785,926 31.6 1,159,720 33.2
48.1 125,774 93,995
78,825 -6.0 796,551 836,384 -4.8 851,454
-6.5
-25.9 54,903 72,414
8,806 10.5
87,790 63,892 37.4
97,025 40.1
72.2
9,235
7,981
228,999 1.4 2,624,864 2,281,120 15.1 2,885,804 15.5
19.8 260,940 238,624
42,802 36.8 514,587 386,497 33.1 564,313 32.5
26.6 49,726 46,781
5 March 2018
12

Laurus Labs
BSE SENSEX
34,047
S&P CNX
10,458
3 March 2018
Update
| Sector:
Healthcare
CMP: INR533
TP: INR613 (+15%)
Buy
USFDA compliance intact; Approval to start US sales
Stock Info
Bloomberg
Equity Shares (m)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
M.Cap. (INR b)
M.Cap. (USD b)
Avg Val, INRm
Free float (%)
LAURUS IN
106
634 / 485
5/-8/-14
57.1
0.9
97.0
69.4
The two positive events for Laurus were Zero 483 at its recent USFDA inspection and
first product approval (g-Viread) from Unit II.
Based on competition and price erosion, we expect Laurus to make USD2-3m from
this product on annualized basis. On overall basis, we expect Laurus to garner US
sales of NR1.3b by FY20 from INR20m in FY17.
Financials Snapshot (INR b)
FY18E FY19E FY20E
Y/E Mar
Net Sales
20.9
25.3
29.2
EBITDA
4.3
5.7
6.8
PAT
2.0
3.1
3.8
EPS (INR)
19.0
29.1
35.7
Gr. (%)
7.0
53.1
22.6
BV/Sh (INR)
144.5 173.0 208.0
RoE (%)
14.1
18.3
18.8
RoCE (%)
11.1
14.1
14.8
P/E (x)
27.9
18.3
14.9
P/BV (x)
3.7
3.1
2.6
Shareholding pattern (%)
As On
Dec-17 Sep-17 Dec-16
Promoter
30.6
30.6
30.6
DII
40.2
41.4
44.4
FII
10.5
10.7
9.1
Others
18.8
17.3
15.9
FII Includes depository receipts
Stock Performance (1-year)
Laurus Labs
Sensex - Rebased
680
Successful Inspection at Unit II (formulation) implies consistency in compliance
and minimal regulatory hurdle:
Laurus successfully cleared recent USFDA
inspection at unit II (formulation) with Zero observations. Facility was inspected
during 26 Feb-1 Mar 2018. USFDA inspection at this facility has been after period of
~one year three months. Till date, unit II has been inspected twice by USFDA and
Laurus has been able to clear it successfully with Establishment Inspection Report
(EIR) in place for previous inspection. Laurus has faced nine inspections successfully
at its different facilities, which implies consistency in regulatory compliance and
minimal regulatory hurdle over medium term. This is commendable given the
scenario, wherein, peers are facing regulatory hurdle to the extent that either
existing business is stopped and/or new approvals have been halted by USFDA.
Laurus to start US sales from maiden approval and subsequent
commercialization:
Laurus also received its first USFDA approval for g-Viread
(Tenofovir Disoproxil Fumarate, TDF) tablets. A TDF tablet is used for treatment of
HIV-1 infection in adults and pediatric patients. The market size of g-Viread is about
~USD1b. Laurus is sixth company to receive final approval for this product in past
two months. Laurus had tentative approval in place. Post patent expiry on 25
January 2018, the final approval was awaited as there was neither any ANDA
specific query pending nor any regulatory issues related to manufacturing. Post
launch by five companies, price erosion has led market size to shrink considerably.
Based on number of competitors and price erosion, we expect Laurus to garner
USD2-3m on annualized basis.
Laurus on track to build robust ANDA pipeline for US market:
LAURUS has filed
eight ANDAs (4 own, 4 with partners). It has target action date (TAD) spread over
CY18 on three products. Laurus intend to file 8-10 ANDAs annually over next 2-3
years, taking cumulative filing to 30. We expect share of US formulation to increase
from INR20m in FY17 to INR1.3b by FY20.
Valuation and view:
We remain positive on Laurus due to additional business from
tender awards in ARV space, new customer addition, increased traction in
Synthesis/ ingredient business and product launches in US. We expect Laurus to
deliver 17% CAGR in sales and 28% CAGR in PAT to INR30b and INR4b over FY17-
20. We value Laurus at 18x (20% premium to midcap average multiple of 15x) 12M
forward earnings to arrive at price target of INR613. Re-iterate Buy on the stock.
610
540
470
400
5 March 2018
13

Exhibit 1:
Revenue share of US formulation…
FY17
Synthesis
6%
FDF Ingredients
3%
0%
Exhibit 2:
…to increase gradually
FY20
Synthesis
11%
FDF
5%
Ingredients
3%
API
91%
Source: MOSL, Company
API
81%
Source: MOSL, Company
Exhibit 3:
We expect 17% CAGR in sales
Total Revenue (INR b)
Growth % (YoY)
25.3
29.2
Exhibit 4:
Superior product mix to drive EBITDA margin
EBITDA Margin
20.4
18.0
15.1
21.4
22.7
20.4
23.3
61.4
11.6
13.3
14.4
17.8
34.0
19.0
20.9
7.1
9.7 21.0
15.4
Source: MOSL, Company
Source: MOSL, Company
Exhibit 5:
Capex intensity to remain stable over few
Exhibit 6:
ROE to improve with better utilization and
years
Capex (INRm)
3,635
2,927
1,198
3,025
2,750
2,500
2,500
product mix
ROE (%)
ROE (%)
16.9
12.6
17.4
14.1
18.3
18.8
Source: MOSL, Company
Source: MOSL, Company
5 March 2018
14

Rain Industries
BSE SENSEX
34,184
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val, INRm
Free float (%)
S&P CNX
10,493
RINDL IN
336
128.1 / 2.0
476 / 85
-4/159/329
850.0
58.9
1 March 2018
Results Update | Sector: Metals
CMP: INR381
TP: INR480(+26%)
Buy
Carbon prices and margins continue to improve
Interest and tax rate declining; Maintain Buy
Rain Industries’ (RAIN) 4QCY17 EBITDA increased 2% QoQ (+58% YoY) to
INR6.9b. Prices increased across products, but carbon product dispatches were
impacted by shipment delays toward the end of the quarter. Adj. PAT increased
37% QoQ to INR3.3b, led by a lower effective tax rate (~21% v/s ~40% in
3QCY17). Exceptional charges include INR0.8b gain from reversal in deferred tax
(due to US and Belgium tax rate changes), offset by INR1.1b toward refinancing
and unabsorbed bond amortization charges.
Carbon – margins improved but shipments delayed:
Volumes fell ~10% QoQ
to 744kt. CPC realization increased by USD78 QoQ to USD415/t and CTP
realization by USD107 to USD708/t. EBITDA/t rose USD15 QoQ to USD133.
Chemical:
Volumes were largely unchanged QoQ at 53kt. Although EBITDA/t
increased USD20 QoQ, it was subdued due to a squeeze in spreads.
Cement – pricing pressure continues:
Sales were largely unchanged QoQ at
509kt. Realization declined 4% QoQ to INR4,173/t. EBITDA/t decreased 3%
QoQ to INR515.
USD25-30m savings on refinancing.
Net debt increased by INR5b YoY to
INR69b due to a massive increase in working capital and appreciation of EUR
against INR. Refinancing of ~USD489m debt is likely to save USD25-30m
every year.
Positive outlook:
CPC business remains strong on declining exports from
China, while CTP is benefitting from consolidation and capacity reduction in
its key markets. Chemical business is likely to turnaround in 2HCY18. Tax rate
is likely to be 200-300bp lower on a reduction in rates in the US and Belgium.
Maintain Buy
:
The stock trades at 8.4x P/E and 5.5x EV/EBITDA on CY19E.
We value the stock at INR480/share (Exhibit 2). Maintain
Buy.
v/s
Est.
%
-3
-6
-1
7
-18
-11
-17
-42
-6
160
1
Financials & Valuations (INR b)
Y/E Dec
2017 2018E
Sales
113.0
148.9
EBITDA
22.7
29.3
NP
8.6
13.7
Adj. EPS (INR)
25.6
40.6
EPS Gr(%)
165.9
58.6
BV/Sh. (INR)
117.3
155.5
RoE (%)
24.7
29.8
RoCE (%)
19.5
26.9
P/E (x)
14.9
9.4
P/BV
3.2
2.5
2019E
163.6
31.1
15.0
44.6
9.8
197.6
25.2
27.9
8.5
1.9
Estimate change
TP change
Rating change
Quarterly Performance (Consolidated) – INR million
Y/E December
Net Sales
Change (YoY %)
EBITDA
As % of Net Sales
Interest
Depreciation
Other Income
PBT (before EO Inc.)
EO Income(exp)
PBT (after EO Inc.)
Total Tax
% Tax
Reported PAT
Less: Min. Int. & assc.
Adjusted PAT
Change (YoY %)
1Q
21,617
-15
1,997
9.2
1,484
817
171
-133
0
-133
-432
324.5
299
6
293
-23.9
CY16
CY17
2Q
3Q
4Q
1Q
2Q
3Q
4Q
25,315 22,400 23,831 24,680 26,371 30,508 31,448
-4
-17
1
14
4
36
32
4,441 4,536
4,347 4,414 4,678 6,738 6,872
17.5
20.2
18.2
17.9
17.7
22.1
21.9
1,513 1,430
1,440 1,536 1,483 1,463 1,465
862
855
927 1,366 1,295 1,335 1,260
322
159
53
206
475
256
198
2,388 2,410
2,032 1,718 2,375 4,195 4,345
162
-224
-933
-670
0
0
-302
2,550 2,185
1,099 1,048 2,375 4,195 4,043
987
466
626
400
819 1,662
868
38.7
21.3
57.0
38.2
34.5
39.6
21.5
1,563 1,719
473
647 1,556 2,534 3,175
-2
42
-19
55
41
78
103
1,403 1,901
1,425 1,263 1,515 2,456 3,374
-12.3
45.7 -1,960.0 331.5
8.0
29.2 136.8
CY16
CY17
4QE
32,300
36
7,302
22.6
1,483
1,175
242
4,887
0
4,887
1,496
30.6
3,390
40
3,351
211.1
93,164 113,007
-9
21
15,321 22,702
16.4
20.1
5,867
5,947
3,461
5,256
704
1,134
6,697 12,633
-996
-973
5,701 11,661
1,648
3,749
28.9
32.1
4,053
7,912
69
285
4,980
8,599
55.1
72.7
5 March 2018
15

Fortis Healthcare
BSE SENSEX
34,047
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
Avg Val, INRm
Free float (%)
S&P CNX
10,047
FORH IN
463.1
65.0 / 1.0
231 / 107
15/1/-35
1120.0
65.6
1 March 2018
Q3FY18 Results Update | Sector: Healthcare
CMP: INR161
TP: INR185 (+15%)
Buy
2Q in-line, but a miss in 3Q; Entry of third-party key for re-rating
Fortis Healthcare (FORH) reported 2QFY18/3QFY18 revenue of INR12b (flat
YoY)/INR11.2b (-1.1% YoY), with EBIDTA margin of 8.9%/4.6%. Hospital
business revenue came in at INR9.7b (-0.6% YoY)/INR9b (-0.9% YoY) for
2QFY18/3QFY18, with EBITDA margin of 8.5%/5.5%. SRL reported revenue of
INR2.2b (+5.2% YoY)/INR2.1b (+10% YoY), with EBITDA margin of 23.2%/18.4%.
2Q numbers were in line, but 3Q numbers missed our expectations. FORH
reported a loss of INR236m/INR191m in 2Q/3QFY18.
Promoter stake down to <1% due to invocation of pledged shares:
Promoter
holding is now down to 0.8% from ~34% in Dec-17 due to invocation of pledged
shares. Yes Bank now is the largest shareholder, with more than 17% stake in
the company. Post invocation of pledge shares, banks and financial institutions
(Yes bank, Axis bank, Indiabulls) have the right to sell their shares to a third
party, which can eventually become the promoter of the company.
Auditors have raised serious issues:
Auditors have raised red flags on related-
party loans and inter-corporate deposits (details provided below).
Consequently, they were unable to express conclusion regarding the financial
statements. Notably, FORH needs to recover loan of ~INR4.7b from promoter
entity. Management responded that it is confident about recovering this loan,
but we see this as a concern, given the financial health of the promoter entity.
SEBI investigation is ongoing related to this issue.
Entry of third-party key for re-rating:
FORH’s stock has remained volatile in the
recent past on the back of news flow related to issues with the current
promoter and possibility of equity infusion in the company. Given that current
promoter holding is marginal, banks/financial institutes may look to find a new
investor, which could lead to stock re-rating. We have valued the hospital and
diagnostic business based on 20x and 18x 1HFY20E EV/EBITDA, respectively.
We cut EBITDA by 26%/9% for FY19/20E as we build in slower margin ramp-up.
FY17E
FY18E
FY17 FY18E FY18E
2Q
3Q
4Q
1Q
2Q
3Q
4QE
3QE
11,957 11,334 11,234 11,566 11,972 11,207 12,242 45,737 46,986 13,034
10.9
8.9
3.2
3.2
0.1
-1.1
9.0
7.8
2.7
15.0
10,968 10,211 10,444 10,705 10,907 10,691 11,157 42,208 43,460 11,587
990 1,123
790
861 1,065
516 1,085 3,529 3,527 1,447
8.3
9.9
7.0
7.4
8.9
4.6
8.9
7.7
7.5
11.1
517
599
630
590
607
590
563 2,222 2,350
780
461
748
666
644
660
632
464 2,294 2,400
500
380
589
361
576
371
426 -1,073 1,660
300
75
393
365
-146
203
169
-280 -1,015
673
-923
242
-9 -4,194
8
6
468
2
0
16
0
0
402 4,559
-153
197
-299
-282 -1,015
657
-923
242
242
190
263
123
170
26
-623
724
-305
80
60.2
4.2 -171.7
62.1
-56.8
-9.2
61.4 110.3
33.0
33.0
-154
-165
-41
-151
-233
-117
258 -4,861
-243
-61
314 4,533
-375
226
-236
-191
-650 4,793
-375
223
310
514
-354
228
497
-189
-650 4,792
-375
223
-62.6 -193.1
-61.0
41.1
60.3 -136.7
83.4 460.3 -107.8
-56.7
2.6
4.5
-3.2
2.0
4.2
-1.7
-5.3
10.5
-0.8
1.7
Var
%
-14
Financials & Valuations (INR b)
Y/E Mar
2018E 2019E 2020E
Net Sales
47.0
52.6
60.5
EBITDA
3.5
5.6
8.8
PAT
-0.4
1.3
3.4
EPS (INR)
-0.8
2.8
7.3
-107.8 -440.1 164.5
Gr. (%)
BV/Sh INR
122.3 125.1 132.3
RoE (%)
-0.7
2.2
5.7
RoCE (%)
1.4
3.1
5.5
P/E (x)
N/A
58.3
22.1
P/BV (x)
1.3
1.3
1.2
Estimate change
TP change
Rating change
Consolidated – Quarterly Earning Model
Y/E March
Net Sales
YoY Change (%)
Total Expenditure
EBITDA
Margins (%)
Depreciation
Interest
Other Income
PBT before EO expense
Extra-Ord expense
PBT
Tax
Rate (%)
MI & P/L of Asso. Cos.
Reported PAT
Adj PAT
YoY Change (%)
Margins (%)
E: MOSL Estimates
1Q
11,212
8.4
10,585
626
5.6
476
420
330
61
0
61
29
47.3
-130
162
162
-82.6
1.4
-64
-186
5 March 2018
16

In conversation
1. REPCO HOME FINANCE : Expect recoveries in both NPAS of
home loans & lap; R Varadarajan, MD
Asset quality deteriorated during Q3. Was not at the expected level but seeing
good amount of recovering happening during the current quarter.
Putting all efforts to bring down the gross non-performing assets (GNPAs) from
the level of 3.7 percent to 2.5 percent. Believe it is doable.
Seeing recoveries happening in LAP segment as well and should be able to show
good improvement there also.
For the current quarter, company is expecting sequential and year-on-year
improvement in the disbursements. But FY19 and FY20 disbursement and loan
growth will be around 20-25 percent.
ALM as of now is very comfortable. Almost all banks are providing funding at
MCLR rate.
Very strongly believe that spread will be maintained.
2. ASHOKA BUILDCON : Macquarie-Ashoka bags Rs 9,700 crore
order; Satish Parakh, MD
TOT is first of its kind and Macquarie has bid for this project. Company will be
operations and maintenance (O&M) partner in this project. So company’s part
will be engineering, procurement and construction (EPC) to the tune of Rs 1,025
crore in first two years and likely to get O&M for the next 30 years.
Another hybrid-annuity model project is Rs 860 crore project to be completed in
two years’ time. Margin from project in partnership with Macquarie will be at
12-13 percent.
Have significant number of projects lined up for the next two quarters.
Will look at bidding for more hybrid annuity model projects.
3. BAJAJ AUTO: Sees robust sales for march; export markets
doing well; S Ravikumar, President - Business Development
Almost all the export markets like Africa, Bangladesh, Nepal, and Philippines are
doing well. New markets are also adding good numbers. Only Columbia seems
to be a dull spot.
Star performer remains the domestic commercial vehicles at 38,000 plus units.
Higher permits in the 3-wheeler space aided sales growth.
Domestic two-wheeler sales were a cause of worry couple of months back but
with new Discover twins, the sales went up to 27000 units this month.
Moreover, with refreshed Avengers and Cruise 220 the numbers are ticking
higher.
Confident of domestic motorcycle sales touching 2 lakh units per month going
forward.
5 March 2018
17

4. RBL BANK : Expect resolution in some stressed assets seen in
Q3FY18; Rajeev Ahuja, ED
Have enough on banks’s plate in terms of business engines. Reaching inflection
points - see great opportunities.
Have grown between 30 percent and 35 percent in all businesses over the last
nine months in a challenging environment.
On Can Fin Homes, there is a sell-down process on but haven’t yet ventured into
the housing segment.
Don’t want to do the large urban housing ticket sizes but in the smaller housing,
bank is interested. Have set up a team to evaluate how Can Fin’s business
shapes up.
Not focused on gold loans as a very large product.
May build a gold loan but nothing right now. The idea is not to acquire
something which is so alien to what bank is prepared to handle.
The December numbers were impacted by one-two specific things which banks
see resolution of. As the microfinance institutions (MFIs) problems get fully
absorbed, should see that dropping overall GNPA.
5. CIPLA : Revenue is a challenge for us; little concerned about
revenue growth; Umang Vohra, MD & Global CEO
Operationally teams have rallied around, tried to improve the outcomes
company has in some key markets.
Have made a couple of definitive shifts – have restructured bio and Europe.
Revenue is a challenge. Little concerned about revenue and where company
could grow them.
Have to factor in disruptions. Something or the other will happen every quarter.
Businesses have to adapt to the same.
India is a sizeable market for company. Growth story is intact in core markets.
Not unduly concerned about growth trajectories within core markets.
5 March 2018
18

From the think tank
1. Indian economy bouncing back, but still not high enough
The Indian economy has been short of good news recently. So the latest GDP
growth figures, released on Wednesday, come as a bit of a relief: The economy
grew at 7.2% in the last three months of 2017, slightly faster than expected. For
the entire financial year—due to end on 31 March—the government’s statisticians
now estimate growth of around 6.6%. This is lower than the 7.5% growth
registered in 2016-17 but, given that in previous quarters of the current financial
year growth was 5.7% and then 6.5%, it’s safe to conclude that the growth
slowdown plaguing India has bottomed out. Still, few will be celebrating. For one,
the slowdown India has endured has been largely self-inflicted. A bad-debt crisis,
an inexplicable decision to ban cash holdings overnight and then a poorly planned
rollout of the new goods and services tax (GST) combined to push Indian growth
well below 6%. It’s hard to cheer a recovery when you shouldn’t have had
anything to recover from in the first place.
2. Taking stock two years after AIIB’S opening
The third annual meeting of the board of governors of the Asian Infrastructure
Investment Bank (AIIB) is scheduled to be held in Mumbai in June. This is fitting;
India is the AIIB’s second-largest shareholder and is also a major recipient of
loans from the bank. The largest shareholder, China, hosted the first annual
meeting in 2016 and the second was hosted by South Korea last year. And with
the bank completing two years since its formal opening in January, it’s a good
time to assess how it has shaped up. The multilateral development bank (MDB)
was established in January 2016 with its headquarters located in Beijing. At the
launch of the AIIB, there were 57 prospective founding members (including
India) and 20 from outside the region (including France Germany, Italy and the
UK). The membership stands at 84 as of end 2017 (the US and Japan being
notably absent).
3. India’s waste management problem
To anyone tuned into Davos last month, Indian leaders presented an impressive
picture of a country open for business. “If you want wealth with wellness, come to
India”, was the message. For those closer to the ground, however, the quality of
life in India’s towns and cities seems distinctly suspect. Here is one important
aspect of this: India generates over 150,000 tonnes of municipal solid waste (MSW)
per day, with Mumbai being the world’s fifth most wasteful city. Yet, only 83% of
waste is collected and less than 30% is treated. According to the World Bank,
India’s daily waste generation will reach 377,000 tonnes by 2025. Blame
urbanization and industrialization, but the consequences of India’s megacities
producing tonnes of waste are tangible and troubling.
5 March 2018
19

4. India is doing well on financial inclusion
Poverty, said Nobel laureate Amartya Sen, is not merely lowness of income, but
deprivation of basic capabilities. This is a fair point. An inclusive financial ecosystem
is quintessential to the social contract. It surmounts both physical and, more
importantly, psychological barriers, and helps achieve sustainable economic
growth. But it doesn’t need a Nobel laureate to underline the ramifications of
excluding large swathes from the development process. It is gratifying that our
policymakers are seized of this imperative and have been working along multiple
avenues to address this. Appropriate frameworks have been, and are being,
designed. And, complementing the focused efforts of the government, the Reserve
Bank of India (RBI) is propagating financial literacy, which lends sustainability to the
inclusion process.
International
5. Fed chairman jerome powell: a seminal debut
The world of asset markets heard the new US Federal Reserve chairman Jerome
Powell for the first time on Tuesday. It did not like what it heard. But, they were
music to my ears. He said: “After easing substantially during 2017, financial
conditions in the United States have reversed some of that easing. At this point,
we do not see these developments as weighing heavily on the outlook for
economic activity, the labour market, and inflation. The FOMC will continue to
strike a balance between avoiding an overheated economy and bringing PCE
price inflation to 2% on a sustained basis.” Powell’s prepared remarks were
rather brief but telling. He does not think that financial market volatility will
have a big bearing on economic activity.
5 March 2018
20

Click excel icon
for detailed
valuation guide
CMP
TP
Valuation snapshot
Company
Automobiles
Amara Raja
Ashok Ley.
Bajaj Auto
Bharat Forge
Bosch
CEAT
Eicher Mot.
Endurance Tech.
Escorts
Exide Ind
Hero Moto
M&M
Mahindra CIE
Maruti Suzuki
Motherson Sumi
Tata Motors
TVS Motor
Aggregate
Banks - Private
AU Small Finance
Axis Bank
DCB Bank
Equitas Hold.
Federal Bank
HDFC Bank
ICICI Bank
IDFC Bank
IndusInd
J&K Bank
Kotak Mah. Bk
RBL Bank
South Indian
Yes Bank
Aggregate
Banks - PSU
BOB
BOI
Canara
Indian Bk
PNB
SBI
Union Bk
Aggregate
NBFCs
Aditya Birla Cap
Bajaj Fin.
Capital First
Cholaman.Inv.&F
n
Dewan Hsg.
GRUH Fin.
HDFC
HDFC Stand. Life
Reco
Buy
Buy
Buy
Buy
Neutral
Buy
Buy
Buy
Sell
Buy
Neutral
Buy
Buy
Buy
Buy
Buy
Neutral
% Upside
EPS (INR)
EPS Gr. YoY (%)
P/E (x)
P/B (x)
ROE (%)
Down-
(INR) (INR)
FY18E FY19E FY20E FY18E FY19E FY20E FY18E FY19E FY18E FY19E FY18E FY19E
side
813
141
3025
783
18676
1581
27735
1340
885
209
3579
733
237
8876
320
371
677
1035
158
4031
880
21951
1899
34764
1540
714
268
3986
884
303
10972
437
515
741
27
12
33
12
18
20
25
15
-19
28
11
21
28
24
37
39
9
28.3
4.9
150.3
20.2
459.1
63.1
829.4
28.2
36.6
8.0
185.0
37.7
9.6
275.6
8.1
28.0
13.9
34.7
41.4
6.2
7.7
174.1 201.6
26.8
35.2
595.2 731.7
84.7 111.7
1,053.0 1,335.0
38.5
51.3
45.6
54.9
10.2
11.6
200.1 212.6
43.9
48.4
12.2
15.1
369.9 471.3
12.5
17.5
57.9
58.5
25.1
33.9
0.9
7.8
6.5
54.2
-3.0
-32.3
34.5
20.1
90.4
-1.3
9.4
37.8
107.8
10.8
5.0
41.1
18.5
19.9
-42.8
-4.4
5.3
-81.6
13.3
18.0
-18.3
0.4
27.0
LP
22.0
33.0
-22.6
24.8
15.6
182.1
Loss
-33.0
16.4
-8.8
978.7
PL
-72.8
NA
42.3
38.9
34.5
26.5
22.1
8.0
5.4
22.7
26.7
15.8
32.7
29.6
34.1
27.0
36.7
24.3
27.5
8.2
16.4
27.2
34.2
54.7
107.1
80.5
45.2
43.9
111.4
22.2
616.0
19.1
20.3
32.0
7.0
29.2
41.6
26.9
43.7
97.1
31.2
35.1
70.7
LP
196.8
19.3
49.5
459.4
LP
2,102
45.2
35.4
30.2
18.7
26.8
18.8
14.0
13.9
19.4
24.0
15.8
31.5
22.9
31.9
26.8
33.2
20.6
13.6
6.2
10.1
23.9
27.4
39.6
1.1
34.9
15.1
28.8
28.7
20.1
38.8
40.7
25.0
33.4
47.5
24.1
26.1
19.4
19.4
24.7
32.2
39.6
13.3
48.6
25.0
23.4
22.6
17.4
29.3
31.4
18.7
26.3
34.8
19.4
20.4
17.9
16.7
19.4
24.0
25.6
6.4
26.9
17.2
39.1
16.9
18.0
22.0
14.5
23.3
18.5
16.1
21.5
5.5
26.4
21.3
6.9
13.4
19.9
8.3
99.4
7.8
7.8
11.9
14.6
17.4
13.8
30.5
26.9
15.0
19.8
11.3
45.4
37.0
83.9
4.6
6.0
4.6
7.6
5.9
2.4
10.6
9.2
3.6
3.3
6.1
3.0
2.4
6.5
7.1
1.8
11.1
4.5
7.4
2.0
2.0
2.2
1.5
4.1
2.3
1.1
4.4
0.7
4.4
3.1
1.0
2.9
2.9
0.9
0.6
0.6
1.0
0.6
1.2
0.5
0.8
4.3
5.8
2.5
4.4
1.9
16.2
5.0
3.0
4.0
5.2
4.2
6.3
5.3
2.2
8.0
7.6
3.1
2.9
5.4
2.7
2.1
5.6
6.0
1.4
8.3
3.7
6.2
1.8
1.8
2.0
1.4
3.6
2.1
1.1
3.7
0.6
3.8
2.8
0.9
2.5
2.6
0.8
0.6
0.6
0.9
0.5
1.1
0.4
0.8
3.3
4.9
2.2
3.7
1.7
13.3
4.3
2.5
17.3
22.1
24.2
21.0
15.2
10.1
36.2
21.0
17.2
12.6
34.0
14.4
10.4
19.8
19.2
14.7
24.9
17.9
14.1
5.9
10.1
1.4
9.4
16.7
8.1
6.8
17.0
8.9
13.2
12.2
6.9
17.6
11.0
18.3
24.7
25.3
23.5
17.9
12.3
34.6
23.9
17.3
14.4
32.0
14.4
11.7
22.8
25.4
24.3
35.3
21.7
17.2
11.1
10.4
9.5
9.8
16.6
10.1
6.9
19.1
11.9
14.3
13.8
12.7
19.9
13.3
Buy
Buy
Neutral
Buy
Buy
Buy
Buy
Neutral
Buy
Buy
Buy
Buy
Buy
Buy
597 705
526 710
162 188
146 205
94
149
1878 2350
305 405
52
65
1697 2076
67
100
1096 1220
485 680
26
38
321 410
18
35
16
41
58
25
33
26
22
50
11
40
46
28
10.6
14.7
7.4
0.9
5.5
67.0
12.5
3.0
61.1
8.6
32.7
15.8
1.9
18.2
15.3
31.0
9.0
6.6
6.5
80.6
16.5
3.2
78.9
12.2
41.5
22.7
3.8
23.9
21.6
44.6
10.9
10.2
8.2
100.9
21.0
3.9
101.4
16.8
54.2
30.3
4.9
30.8
41.1 56.2
43.7 35.8
21.4 22.0
53.4 157.3
26.1 17.2
25.2 28.0
27.6 24.4
21.9 17.2
28.5 27.8
37.7 7.8
30.5 33.5
33.2 30.7
30.4 13.6
28.8 17.6
29.8 26.9
42.0
222.3
89.1
14.5
84.7
65.3
158.0
71.3
42.4
34.2
27.5
21.5
26.1
23.4
16.3
25.2
14.2
NM
23.1
9.3
17.8
81.8
NM
304.4
44.2
36.4
19.5
23.5
14.3
53.9
42.1
95.6
Buy
Neutral
Neutral
Buy
Buy
Buy
Neutral
138
113
291
317
101
263
104
185
150
415
430
215
375
145
34
33
43
36
113
43
40
9.8
-15.6
12.6
34.1
5.7
3.2
-40.5
16.7
1.1
37.3
40.6
8.5
18.0
5.9
23.7
3.7
70.6
46.5
15.7
29.7
15.3
2.0
5.5
-6.5 0.6
2.3
6.8
10.8 11.9
2.9
4.3
1.6
8.4
-16.7 2.7
0.3
5.7
12.6
20.1
13.7
20.4
14.0
32.9
17.6
21.7
12.4
19.8
15.6
20.2
15.8
32.2
16.5
21.1
Buy
Buy
Buy
Buy
Buy
Neutral
Buy
Buy
163 225
1658 2330
669 960
1452 1520
537 720
535 540
1813 2260
451 485
38
41
44
5
34
1
25
8
3.7
45.6
34.2
61.8
37.4
9.9
43.0
4.7
5.3
61.7
44.6
73.3
47.5
11.8
49.0
5.4
7.6
82.8
56.8
89.1
59.9
14.6
57.0
6.7
5 March 2018
21

Click excel icon
for detailed
valuation guide
CMP
Company
Reco
TP
% Upside
EPS (INR)
Down-
FY18E FY19E FY20E
side
30
91.1 105.1 128.3
48
7.4
11.0
13.5
20
38.5 44.3
52.6
26
18.6 24.2
30.0
34
13.9 19.2
23.0
22
43.8 44.8
49.3
45
51.4 69.0
92.3
29
33.4 39.0
46.0
25
31
114.2 140.0 166.8
78.7
104.8 125.9
EPS Gr. YoY (%)
Valuation snapshot
P/E (x)
P/B (x)
ROE (%)
(INR) (INR)
1258 1630
162 240
507 608
594 750
428 575
388 475
1210 1750
572 740
2006 2500
1338 1750
FY18E FY19E FY20E FY18E FY19E FY18E FY19E FY18E FY19E
32.8
42.2
0.6
24.0
95.8
48.1
62.4
14.6
35.4
42.1
28.2
12.1
12.6
123.6
36.0
9.8
-72.2
-12.4
84.1
19.4
35.5
15.7
10.9
18.4
-7.4
76.0
16.4
17.2
29.5
31.3
-69.0
41.2
-47.5
-33.4
31.8
34.7
-10.8
LP
713.3
LP
102.0
10.0
-7.4
-7.7
2.7
14.3
12.9
4.5
-9.6
10.6
15.4
47.1
15.2
29.6
38.7
2.3
34.4
16.8
22.6
33.1
22.8
52.0
12.0
-2.6
48.2
26.1
63.3
34.6
9.6
21.6
16.6
18.8
53.8
21.5
21.4
4.9
12.4
19.9
38.4
31.1
378.7
41.5
235.5
101.9
27.3
97.2
25.3
66.8
113.1
101.0
53.5
3.0
53.0
74.3
18.8
24.8
17.9
19.2
30.5
15.1
22.1
23.2
18.7
24.1
19.4
10.2
33.7
18.1
19.2
20.2
22.6
16.2
6.3
37.5
26.9
18.4
58.8
18.6
13.9
24.1
28.5
19.2
13.8
23.7
12.5
10.3
13.8
18.8
13.8
21.8
13.2
31.9
30.8
8.9
23.6
17.1
17.6
17.0
28.7
77.1
21.6
30.3
45.6
45.4
71.9
34.6
39.6
44.8
25.5
26.8
58.4
41.8
42.4
16.5
34.3
32.4
12.0
14.8
11.4
24.6
22.2
8.7
17.5
14.7
14.3
12.8
23.3
50.7
19.3
31.1
30.8
36.0
44.0
25.7
36.1
36.8
21.9
22.6
38.0
34.4
34.9
15.8
30.6
27.0
30.3
26.3
21.4
35.4
9.8
20.8
18.1
23.2
24.3
29.3
26.7
19.1
13.2
38.1
30.5
24.1
43.7
47.0
37.4
36.0
34.5
44.8
3.9
3.2
2.0
4.5
2.9
2.0
3.3
2.7
2.3
2.4
4.3
9.0
3.9
1.0
9.0
19.9
1.2
5.6
8.8
8.7
5.5
3.4
5.3
7.7
4.9
2.7
5.5
3.6
2.5
3.4
2.1
4.5
1.7
0.9
3.5
3.4
4.2
3.2
6.1
2.4
2.1
6.4
4.3
3.4
13.8
18.2
21.5
10.2
12.3
10.8
3.4
2.7
1.8
3.9
2.7
1.7
2.8
2.3
2.1
2.1
3.7
7.8
3.5
1.0
8.4
16.3
1.2
5.2
7.6
7.6
4.6
3.0
4.9
6.6
4.4
2.4
4.8
3.3
2.4
3.2
2.0
4.0
1.4
0.9
3.0
3.0
3.6
2.9
5.1
2.2
1.8
5.6
3.9
3.0
12.2
15.6
20.1
9.1
10.8
9.5
29.9
15.9
16.4
20.2
10.9
24.3
14.7
16.9
14.1
14.9
15.0
11.6
17.9
3.4
20.4
50.6
1.7
16.7
24.1
19.4
21.6
13.0
9.1
20.0
12.1
17.1
16.9
11.0
6.1
10.1
2.1
9.4
5.2
2.2
16.4
7.7
14.4
6.6
11.2
6.5
10.8
17.6
9.7
8.0
26.9
33.9
49.9
25.4
29.0
23.6
30.4
19.7
16.5
17.0
12.5
21.0
17.4
16.9
15.2
17.5
15.8
15.4
18.0
3.3
28.3
49.8
2.7
20.8
22.7
20.8
21.0
14.1
12.9
20.6
13.4
15.8
16.8
12.2
8.0
12.6
9.6
12.0
15.7
4.4
17.8
13.8
15.9
10.3
20.9
12.0
14.6
15.7
13.5
12.5
29.6
35.8
55.5
26.7
33.2
22.6
Indiabulls Hsg
Buy
L&T Fin Holdings Buy
LIC Hsg Fin
Neutral
MAS Financial
Buy
M&M Fin.
Buy
Muthoot Fin
Neutral
PNB Housing
Buy
Repco Home
Buy
Shriram
City
Buy
Union
Shriram Trans. Buy
Aggregate
Capital Goods
ABB
Sell
Bharat Elec.
Buy
BHEL
Sell
Blue Star
Neutral
CG Cons. Elec.
Buy
CG Power & Indu. Neutral
Cummins
Buy
GE T&D
Neutral
Havells
Buy
K E C Intl
Neutral
L&T
Buy
Siemens
Neutral
Solar Ind
Neutral
Thermax
Neutral
Va Tech Wab.
Buy
Voltas
Neutral
Aggregate
Cement
Ambuja Cem.
Neutral
ACC
Neutral
Birla Corp.
Buy
Dalmia Bharat
Buy
Grasim Inds.
Neutral
India Cem
Neutral
J K Cements
Buy
JK Lakshmi Ce
Buy
Ramco Cem
Buy
Orient Cem
Buy
Prism Cem
Buy
Sagar Cements Not Rated
Sanghi Inds.
Buy
Shree Cem
Buy
Ultratech
Buy
Aggregate
Consumer
Asian Paints
Neutral
Britannia
Buy
Colgate
Buy
Dabur
Buy
Emami
Buy
Godrej Cons.
Neutral
1528
153
91
756
233
82
804
417
511
410
1313
1154
1021
1211
550
618
1240
210
80
780
305
90
1040
435
640
385
1650
1285
1100
1250
700
630
-19
37
-12
3
31
10
29
4
25
-6
26
11
8
3
27
2
19.8
7.1
3.0
16.6
5.1
1.1
23.2
10.6
11.4
16.1
49.0
19.8
24.4
28.6
33.2
18.0
30.1
7.9
2.9
24.6
6.5
1.9
31.3
11.6
13.9
18.7
58.1
30.4
29.6
34.7
34.8
20.2
35.0
8.4
4.0
31.2
7.7
3.0
37.1
13.2
17.2
24.1
69.3
34.6
36.7
39.0
38.4
23.0
253
1634
905
2740
1167
157
1026
430
742
161
127
966
118
16617
4150
290
1781
1234
3328
1242
148
1343
470
847
179
159
-
157
22424
5131
15
9
36
21
6
-6
31
9
14
12
26
33
35
24
6.0
8.3
10.9
47.4 62.2
76.9
8.9
42.4
50.6
54.7 77.4 107.6
35.6 119.4 145.0
3.7
7.6
10.4
44.4 56.5
76.9
9.4
18.5
25.0
24.3 30.5
38.8
3.3
5.5
10.3
2.2
4.7
6.3
25.2 50.6
70.6
5.8
8.9
12.0
423.0 435.8 724.2
89.0 136.2 178.4
30.4 41.9
23.6 34.5
19.5 102.2
39.0 50.1
21.4 32.8
37.7 42.0
36.0 23.1
35.2 45.8
27.2 30.5
88.7 48.8
33.4 57.0
39.7 38.4
34.6 20.3
66.2 39.3
31.1 46.6
31.2 42.1
20.2
25.1
19.7
16.2
19.1
14.2
51.9
58.6
44.1
43.0
45.0
51.5
1120
4939
1058
325
1081
1077
1270
5995
1365
415
1505
1065
13
21
29
28
39
-1
21.6
84.2
24.0
7.6
24.0
20.9
25.6
30.8
105.1 131.5
28.3
33.8
9.0
10.5
31.3
37.3
24.1
27.5
5 March 2018
22

Click excel icon
for detailed
valuation guide
CMP
Company
GSK Cons.
HUL
ITC
Jyothy Lab
Marico
Nestle
Page Inds
Parag Milk
Pidilite Ind.
P&G Hygiene
Prabhat Dairy
United Brew
United Spirits
Aggregate
Healthcare
Alembic Phar
Alkem Lab
Ajanta Pharma
Aurobindo
Biocon
Cadila
Cipla
Divis Lab
Dr Reddy’s
Fortis Health
Glenmark
Granules
GSK Pharma
IPCA Labs
Jubilant Life
Laurus Labs
Lupin
Sanofi India
Shilpa Medicare
Strides Shasun
Sun Pharma
Torrent Pharma
Aggregate
Infrastructure
Ashoka Buildcon
IRB Infra
KNR
Constructions
Sadbhav
Engineering
Aggregate
Logistics
Allcargo Logistics
Concor
Gateway
Distriparks
Aggregate
Media
Dish TV
D B Corp
Reco
Neutral
Buy
Neutral
Neutral
Neutral
Neutral
Buy
Neutral
Buy
Neutral
Not Rated
Buy
Neutral
(INR)
6793
1326
264
344
312
7851
21875
278
895
9401
170
1054
3246
% Upside
EPS (INR)
Down-
(INR)
FY18E FY19E FY20E
side
6350
-7
161.0 183.8 215.7
1585
20
23.1 27.9
32.9
278
5
9.0
10.2
11.4
380
11
8.1
10.7
13.3
345
11
6.4
7.6
9.0
7882
0
140.0 159.1 192.3
27490
26
297.1 415.7 549.8
314
13
8.9
12.4
16.8
1050
17
17.7 20.8
24.1
9303
-1
142.1 171.3 200.8
-
3.5
6.4
9.7
1380
31
14.1 17.4
22.9
3515
8
32.9 57.0
78.7
TP
EPS Gr. YoY (%)
Valuation snapshot
P/E (x)
P/B (x)
ROE (%)
FY18E FY19E FY20E FY18E FY19E FY18E FY19E FY18E FY19E
3.1
17.6
6.6
-27.7
1.2
13.2
24.5
147.7
5.7
6.9
-2.0
62.0
22.9
9.0
14.1
20.7
13.7
32.0
19.2
13.6
39.9
38.7
17.8
20.5
83.8
23.9
73.4
18.5
17.4
18.1
12.4
24.2
18.4
20.8
32.2
35.6
15.5
17.3
52.1
31.2
38.1
17.3
19.0
23.5
23.6
10.1
81.5
15.8
22.0
19.7
28.0
71.9
24.7
38.7
11.2
27.7
15.8
22.8
34.6
15.5
26.1
36.7
27.7
28.0
24.9
42.2
57.4
29.4
42.3
49.0
56.1
73.6
31.2
50.6
66.2
49.0
74.9
98.8
45.0
23.1
33.1
25.9
14.0
82.2
24.0
26.0
31.0
30.0
85.4
17.8
18.3
48.4
31.8
17.4
28.0
24.9
35.8
32.9
50.3
39.4
27.8
29.1
37.0
47.6
25.9
32.1
41.1
49.3
52.6
22.5
42.9
54.9
26.7
60.5
57.0
38.0
21.8
24.9
21.3
12.8
57.4
19.2
21.5
23.1
19.7
32.8
16.5
14.6
43.3
23.3
13.3
18.3
20.0
31.4
16.5
17.4
24.4
21.7
22.0
24.1
9.2
21.7
24.9
15.4
13.9
25.6
19.8
22.9
44.5
14.4
8.4
43.6
6.4
5.9
15.2
23.6
29.3
3.2
11.8
37.2
2.3
10.5
17.1
12.1
4.7
5.2
6.3
3.1
7.3
5.0
3.3
5.2
2.9
1.3
2.9
2.1
11.6
3.2
3.2
3.7
2.5
5.8
3.4
2.3
3.4
4.6
3.7
2.3
1.3
3.8
3.6
2.1
2.2
3.4
2.2
3.1
17.7
3.3
7.6
43.4
5.9
5.8
14.4
22.1
23.5
2.8
10.1
31.1
2.2
9.1
12.7
11.0
4.0
4.5
5.0
2.5
6.7
4.2
2.9
4.6
2.5
1.2
2.5
1.9
13.2
2.9
2.6
3.1
2.3
5.3
2.9
2.0
3.1
4.1
3.3
2.1
1.2
3.3
3.2
1.9
2.0
3.2
2.1
2.9
20.7
76.5
22.8
13.8
33.0
43.4
39.9
10.8
25.2
61.2
4.9
14.9
17.3
26.9
21.8
16.7
27.0
24.6
8.9
22.7
12.8
16.6
10.0
1.6
16.4
13.2
23.9
10.5
19.7
14.1
10.4
16.1
11.0
4.6
8.8
17.6
12.7
5.5
15.5
23.6
13.5
13.3
11.7
11.2
6.5
10.6
21.6
91.4
23.8
18.3
36.0
46.2
44.6
13.3
25.4
61.8
8.5
16.2
22.3
28.9
19.7
19.3
26.2
21.6
11.6
23.7
13.6
21.2
13.7
3.9
15.3
13.9
30.5
13.0
21.4
18.3
12.0
16.8
19.0
12.1
13.3
19.9
14.9
8.9
13.4
16.2
13.7
12.3
15.3
12.9
10.7
12.6
Neutral
Buy
Buy
Buy
Neutral
Buy
Neutral
Neutral
Neutral
Buy
Neutral
Buy
Neutral
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Neutral
553
2213
1400
624
626
404
582
1017
2228
161
543
116
2379
681
834
533
804
5077
438
710
535
1333
555
2500
1840
820
600
500
600
1100
2575
185
550
175
2500
750
1110
613
940
5600
749
989
675
1400
0
13
31
31
-4
24
3
8
16
15
1
51
5
10
33
15
17
10
71
39
26
5
23.9 25.3
30.1 10.8 5.9
66.8 88.9 109.9 -10.5 33.2
54.0 65.8
81.4 -5.8 21.9
44.5 48.7
53.6 13.2 9.4
7.6
10.9
19.8 -25.3 43.1
16.8 21.0
24.4 18.5 25.0
22.4 27.0
33.0 40.9 20.6
32.9 44.0
52.7 -17.7 33.9
74.4 113.2 145.0 2.4 52.2
1.9
4.9
8.4 -81.8 160.8
30.6 32.9
41.1 -22.2 7.7
6.3
7.9
11.0 -12.4 25.2
49.1 54.9
61.1 42.9 11.9
21.4 29.2
37.3 33.2 36.6
47.8 62.6
72.5 29.5 30.9
19.0 29.1
35.7
7.0 52.7
32.3 40.2
54.1 -43.0 24.6
141.7 161.8 186.9 9.8 14.2
13.3 26.5
33.4 -5.0 99.2
14.1 40.8
55.7 -56.2 188.8
13.6 21.9
27.9 -48.1 61.4
48.0 61.3
78.5 -12.9 27.6
-16.9 32.7
5.3
25.4
16.9
13.9
9.5
24.6
14.0
16.0
19.1
21.3
18.2
17.4
LP
24.8
Buy
Neutral
Buy
Buy
229
225
303
398
290
250
375
460
27
11
24
16
79.9 101.0 43.4
-3.0 -13.6 8.9
18.0
28.6
15.9
41.2 -17.3 30.2
27.1
14.9
8.6
Buy
Neutral
Buy
179 223
1310 1469
210
237
25
12
13
8.9
41.9
6.2
12.9
51.2
10.6
14.9
58.2
13.1
-9.3
10.3
-9.0
5.3
44.2
22.3
71.3
28.5
15.8
13.5
23.4
14.6
20.1
31.3
33.9
29.5
Buy
Buy
71
332
101
420
41
27
-0.5
18.8
1.6
23.0
3.4
27.6
PL
-7.6
LP 109.9 NM
22.0 20.1 17.6
12.7 -11.9 33.2
2.8 20.1 20.9
5 March 2018
23

Click excel icon
for detailed
valuation guide
CMP
Company
Den Net.
Ent.Network
Hathway Cable
Hind. Media
HT Media
Jagran Prak.
Music Broadcast
PVR
Prime Focus
Siti Net.
Sun TV
Zee Ent.
Aggregate
Metals
Hindalco
Hind. Zinc
JSPL
JSW Steel
Nalco
NMDC
SAIL
Rain Industries
Vedanta
Tata Steel
Aggregate
Oil & Gas
BPCL
GAIL
Gujarat Gas
Gujarat St. Pet.
HPCL
IOC
IGL
Mahanagar Gas
MRPL
Oil India
ONGC
PLNG
Reliance Ind.
Aggregate
Retail
Jubilant Food
PC Jeweller
Titan Co.
Aggregate
Technology
Cyient
HCL Tech.
Hexaware
Infosys
KPIT Tech
L&T Infotech
Mindtree
Mphasis
Reco
Neutral
Buy
Buy
Buy
Neutral
Buy
Buy
Buy
Buy
Neutral
Buy
Buy
TP
% Upside
EPS (INR)
Down-
FY18E FY19E FY20E
side
-10
-2.9
0.1
4.0
14
8.3
16.4
28.7
28
-0.2
0.8
2.0
27
25.9 28.8
32.4
28
11.8 12.1
12.7
29
9.9
12.5
15.2
19
8.2
13.5
17.8
35
22.1 37.3
51.5
27
2.5
5.8
7.9
45
-0.9
0.1
0.6
33
27.7 35.8
42.5
27
13.7 17.6
21.0
EPS Gr. YoY (%)
Valuation snapshot
P/E (x)
P/B (x)
ROE (%)
(INR) (INR)
100
90
721 820
37
47
240 305
91
117
167 215
394 469
1303 1760
102 130
19
27
918 1225
557 705
FY18E FY19E FY20E FY18E FY19E FY18E FY19E FY18E FY19E
Loss
-27.7
Loss
0.2
59.3
-6.9
27.8
7.8
100.6
Loss
11.6
2.1
12.1
127.9
9.6
Loss
39.8
PL
37.6
Loss
165.6
57.4
51.9
66.7
-22.0
17.4
28.2
40.1
-14.7
-7.7
7.4
27.0
-15.0
-22.6
7.1
24.3
19.6
3.4
186.2
44.4
38.8
48.6
18.1
3.1
21.2
2.6
0.8
18.5
31.5
12.9
LP
98.0
LP
11.3
2.6
26.4
64.9
68.7
137.5
LP
29.1
28.7
43.8
5,545
75.7
161.9
12.6
4.9
21.5
31.4
37.9
36.4
411.6
18.7
19.3
28.1
NM 1,401.3 2.3
87.2 44.0
3.9
NM 48.4
2.6
9.3
8.3
1.3
7.8
7.6
0.8
16.9 13.4
2.6
48.0 29.1
3.8
58.9 34.9
5.7
41.6 17.5
4.3
NM 147.3 3.6
33.1 25.6
8.3
40.7 31.6
6.9
37.7 26.2
5.3
8.9
9.5
34.3
12.7
13.1
9.3
18.7
9.1
7.8
9.7
9.8
10.7
14.0
26.4
15.7
12.0
10.9
27.7
19.4
10.2
8.6
8.1
15.0
14.2
11.8
51.1
17.0
50.9
40.5
15.6
14.7
18.7
16.4
16.2
19.0
19.9
17.0
1.6
6.4
0.8
2.7
1.3
1.7
0.9
3.2
2.1
1.7
1.9
2.5
1.9
6.4
2.3
2.6
1.6
6.3
5.0
1.8
0.9
1.1
3.8
1.9
1.7
14.9
3.4
13.7
9.9
3.1
3.7
5.2
4.2
2.4
6.2
5.1
3.3
2.2
3.6
2.5
1.1
0.8
2.3
3.3
5.0
2.7
3.5
7.5
5.9
4.6
1.4
4.5
0.8
2.3
1.3
1.5
0.9
2.4
1.9
1.5
1.7
2.2
1.7
5.3
2.0
2.3
1.5
5.3
4.5
1.5
0.9
1.0
3.2
1.7
1.5
15.2
2.9
12.7
9.0
2.8
3.4
4.5
3.6
2.1
4.9
4.5
3.0
-6.3
4.5
-1.2
15.1
11.5
15.3
8.2
10.2
11.6
-15.8
26.1
18.2
14.0
14.0
35.3
-3.6
20.2
-0.9
18.4
-1.0
25.3
15.1
15.9
12.3
22.7
11.3
16.1
14.6
24.9
17.3
20.8
28.0
20.2
7.1
10.0
23.9
12.8
12.9
22.5
16.9
23.4
19.2
17.4
25.1
26.9
24.3
14.3
32.1
19.9
15.3
0.2
8.4
5.2
14.6
10.6
18.4
12.2
15.3
18.9
2.4
30.9
20.0
17.4
16.8
55.7
2.3
19.5
9.8
17.3
4.8
30.1
25.4
16.3
16.8
21.8
12.8
22.0
13.6
20.2
14.4
20.8
24.4
16.2
10.5
12.8
22.9
12.7
13.2
29.8
18.4
25.9
22.2
17.8
23.9
25.8
23.1
13.8
29.0
24.0
18.7
Buy
Neutral
Buy
Buy
Neutral
Buy
Sell
Buy
Buy
Neutral
240
316
249
306
67
131
81
362
323
675
344
342
361
339
79
215
71
480
416
778
43
8
45
11
17
64
-12
26
29
15
19.5
21.6
-11.5
20.7
-0.5
13.7
-0.9
25.6
23.8
57.7
27.0
33.3
7.3
24.0
5.1
14.0
4.3
39.6
41.7
69.4
27.9
32.1
11.9
23.7
5.3
14.7
6.5
43.4
43.4
61.5
38.6 3.0 12.3
54.6 -3.8 14.6
LP
63.4 NM
15.9 -1.0 14.8
LP
2.6
NM
2.2
4.7
9.5
LP
50.2 NM
54.8 9.7 14.2
74.8 4.2 13.6
20.4 -11.5 11.7
55.3 1.7 15.3
9.2
22.0
59.6
4.1
-9.4
-9.4
17.2
-3.6
-7.7
56.7
32.5
13.4
10.3
11.8
29.6
26.6
27.0
27.2
12.1
3.8
10.9
9.7
10.5
13.7
24.6
14.8
11.3
4.6
28.7
8.3
15.8
21.1
13.2
1.2
5.0
3.3
4.1
17.9
11.6
10.6
31.3
27.6
24.1
26.0
13.2
7.5
13.4
11.2
29.1
15.2
17.2
8.3
11.7
17.1
42.1
16.4
10.9
9.9
32.4
18.7
9.4
13.4
10.8
17.1
15.7
13.1
66.2
21.6
64.7
51.5
17.5
15.3
20.7
18.0
17.9
21.6
24.8
19.5
Buy
Sell
Buy
Neutral
Buy
Buy
Buy
Buy
Neutral
Buy
Buy
Buy
Buy
442 549
453 388
866 1014
202 188
377 530
381 513
306 416
1048 1228
118 114
350 425
190 230
241 318
948 1111
24
-14
17
-7
41
35
36
17
-3
21
21
32
17
37.7
26.5
20.6
12.3
34.7
38.7
9.4
55.9
12.6
26.1
17.6
14.1
60.4
41.2
32.3
32.9
12.8
31.5
35.0
11.1
53.9
11.6
40.9
23.3
16.0
66.6
45.8
33.8
42.3
13.9
36.4
42.4
12.5
54.6
12.2
42.2
24.3
18.9
74.3
Neutral
Buy
Buy
2008 2185
333 685
810 990
9
106
22
30.3
15.4
12.5
39.3
19.5
15.9
51.6
24.9
19.8
Buy
Neutral
Neutral
Buy
Neutral
Buy
Buy
Neutral
634 675
944 950
344 340
1160 1250
215 219
1417 1400
811 725
855 800
7
1
-1
8
2
-1
-11
-6
36.2
61.7
16.6
64.4
12.0
65.7
32.7
43.9
40.6
64.1
18.4
70.7
13.3
74.7
40.8
50.4
45.9
68.9
20.9
78.6
17.2
86.1
47.8
54.6
5 March 2018
24

Click excel icon
for detailed
valuation guide
CMP
Company
NIIT Tech
Persistent Sys
Tata Elxsi
TCS
Tech Mah
Wipro
Zensar Tech
Aggregate
Telecom
Bharti Airtel
Bharti Infratel
Idea Cellular
Tata Comm
Aggregate
Utiltites
Coal India
CESC
JSW Energy
NHPC
NTPC
Power Grid
Tata Power
Aggregate
Others
Arvind
Avenue
Supermarts
Bata India
BSE
Castrol India
Coromandel Intl
Delta Corp
Eveready Inds.
Interglobe
Indo Count
Info Edge
Kaveri Seed
Manpasand
MCX
Monsanto
Navneet
Education
Oberoi Realty
Quess Corp
PI Inds.
Piramal Enterp.
SRF
S H Kelkar
Team Lease Serv.
Trident
TTK Prestige
UPL
V-Guard
Reco
Neutral
Buy
Buy
Neutral
Buy
Neutral
Buy
TP
% Upside
EPS (INR)
Down-
FY18E FY19E FY20E
side
-8
44.6 52.2
60.6
8
43.1 53.0
60.5
18
36.8 43.6
51.5
-11
130.6 147.3 161.0
15
39.2 40.9
47.7
3
17.9 18.5
21.2
24
54.2 64.1
85.2
EPS Gr. YoY (%)
Valuation snapshot
P/E (x)
P/B (x)
ROE (%)
(INR) (INR)
872 800
837 900
1045 1236
3037 2700
611 700
292 300
890 1100
FY18E FY19E FY20E FY18E FY19E FY18E FY19E FY18E FY19E
17.4
14.4
30.8
-2.1
26.8
6.0
4.0
4.2
-68.7
-6.1
Loss
-75.8
PL
16.9
22.8
18.4
12.8
4.5
3.2
18.3
5.1
16.2
14.3
18.2
9.3
16.6
14.7
33.1
11.1
19.5
19.4
28.4
23.3
15.6
16.3
16.4
19.4
16.7
15.8
24.0
20.6
14.9
15.8
13.9
18.5
3.1
3.3
9.1
7.3
3.1
2.9
2.4
4.9
2.8
3.2
7.3
6.3
2.7
2.4
2.1
4.3
16.1
17.8
36.0
30.4
20.6
17.2
15.7
25.0
17.6
21.0
33.8
32.9
19.5
16.7
16.4
23.1
Buy
Neutral
Buy
Buy
427
343
83
638
680
380
110
750
59
11
33
18
3.5
3.9
14.0 16.2
-10.7 -11.6
2.4
11.6
7.2
17.8
-9.7
23.6
12.2 84.4 122.6 109.3 2.5
16.5 9.7 24.6 21.1
4.3
Loss Loss NM
NM
1.3
383.2 102.9 265.3 54.9 13.0
Loss
LP -458.3 -1,625 2.6
16.9
11.3
18.9
11.5
12.7
11.7
17.3
13.8
36.6
11.7
10.6
22.3
8.9
11.0
9.7
11.6
10.9
29.5
76.2
37.5
17.6
30.6
18.9
42.3
23.5
17.4
10.0
49.3
12.2
29.5
26.2
20.0
13.8
10.6
31.0
25.0
21.9
18.4
27.9
34.1
7.8
39.4
15.2
39.9
7.6
1.2
1.2
1.0
1.3
1.8
1.8
2.0
2.9
18.7
6.3
1.6
19.5
4.8
5.9
8.4
7.6
1.9
7.3
3.5
3.6
3.0
7.5
4.0
2.8
5.7
6.3
2.3
3.1
4.7
7.6
1.2
8.6
4.0
12.9
2.5
2.1
2.3
4.3 17.0 20.4
1.7 -18.1 -20.9
10.5 4.6 21.2
2.7 -0.6 -0.2
7.1
1.1
1.2
1.0
1.2
1.6
1.6
1.9
2.7
15.9
5.5
1.3
18.4
4.1
5.3
6.8
7.1
1.6
6.6
3.1
3.3
2.8
6.4
3.5
2.3
4.6
5.3
2.1
2.8
4.2
6.2
1.1
7.7
3.3
10.3
44.7
10.6
6.7
8.5
10.5
16.5
10.8
14.8
8.0
19.0
14.6
8.5
69.1
22.5
12.6
27.1
46.8
16.0
13.7
23.4
7.4
7.9
32.5
23.9
7.8
21.7
22.6
8.9
14.1
13.4
17.7
12.6
18.0
26.3
26.9
60.8
10.4
5.5
10.8
11.3
17.5
14.5
17.3
9.4
22.6
15.7
7.4
61.8
23.4
13.2
32.0
42.1
17.4
14.0
27.1
11.8
11.0
34.5
26.9
24.2
21.0
22.9
10.2
15.9
16.0
20.1
14.5
20.7
23.6
28.8
Buy
Buy
Sell
Buy
Buy
Buy
Sell
313 401
1005 1408
81
61
28
37
163 210
197 282
84
74
28
40
-24
33
29
43
-12
18.5
88.8
4.3
2.4
12.9
16.9
4.9
26.8
95.2
3.6
3.1
14.8
20.4
7.3
31.1 23.8 44.9 16.2
103.2 71.1 7.3
8.4
4.0
11.4 -15.4 10.7
3.2 -18.1 28.5 3.1
16.2
7.5 15.1 9.5
21.3 20.7 20.9 4.6
7.9
-5.8 49.0 8.6
14.5 26.3 10.3
18.8
23.0
-8.4
63.6
23.8
37.4
34.1
Neutral
Sell
Sell
Neutral
Buy
Buy
Buy
Buy
Neutral
Neutral
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Buy
Neutral
Buy
Neutral
415
1313
723
801
202
550
352
394
1330
99
1296
494
391
771
2537
135
511
1015
884
2548
1894
290
2033
72
6940
715
237
402
920
578
950
242
523
382
458
1307
117
1550
664
467
1100
3293
194
608
1300
988
3500
2040
343
2700
114
5281
945
167
-3
-30
-20
19
20
-5
9
16
-2
18
20
35
19
43
30
44
19
28
12
37
8
18
33
58
-24
32
-30
11.3
12.6
14.1
17.2
33.4 104.6
16.6
8.6
4.3
4.5
34.0
24.1
44.4
17.7
27.1
17.0
35.6
18.5
18.4
17.6
-3.5
27.3
16.4
27.1
32.1
17.7
47.9
25.8
15.4
17.9
12.1
45.4
19.2
28.8
22.8
59.5
33.5
20.8
13.2
55.5
14.4
43.5
37.0
24.2
17.8
37.5
45.8
30.1
30.6
22.8
36.7
46.9
10.1
50.3
16.6
53.0
15.9 19.3
22.4 17.8 21.0
41.8 45.5
49.4
2.0
8.7
7.0
6.6
6.9
2.9 -5.9
24.1 29.0
30.3 45.1 20.4
5.9
8.3
11.2 93.7 40.7
11.7 16.7
20.8 -8.7 42.5
64.0 76.4 110.4 48.2 19.3
7.5
9.9
11.7 -42.2 32.0
23.4 26.3
33.4 49.0 12.5
34.2 40.6
47.4 79.5 18.5
9.0
13.2
17.9 41.6 47.2
20.8 29.4
34.9 -16.0 41.1
105.0 126.6 149.9 21.9 20.6
7.6
9.7
11.4
3.6
28.4
13.6 48.2
46.5 22.3 253.5
22.1 32.7
41.6 124.2 47.7
29.3 35.4
41.2 -12.2 20.6
83.1 116.4 147.9 14.5 40.0
82.9 103.0 136.0 -3.5 24.2
7.9
10.4
12.2
9.1 31.6
43.3 59.6
88.1 11.6 37.5
7.2
9.2
11.6
8.4 28.1
137.8 176.1 203.2 4.4 27.8
43.0 47.2
55.6
8.9
9.7
4.5
6.0
6.7
25.3 32.9
5 March 2018
25

MOSL Universe stock performance
Company
Automobiles
Amara Raja
Ashok Ley.
Bajaj Auto
Bharat Forge
Bosch
CEAT
Eicher Mot.
Endurance Tech.
Escorts
Exide Ind
Hero Moto
M&M
Mahindra CIE
Maruti Suzuki
Motherson Sumi
Tata Motors
TVS Motor
Banks - Private
AU Small Fin. Bank
Axis Bank
DCB Bank
Equitas Hold.
Federal Bank
HDFC Bank
ICICI Bank
IDFC Bank
IndusInd
J&K Bank
Kotak Mah. Bk
RBL Bank
South Indian
Yes Bank
Banks - PSU
BOB
BOI
Canara
Indian Bk
PNB
SBI
Union Bk
NBFCs
Aditya Birla Cap
Bajaj Fin.
Capital First
Cholaman.Inv.&Fn
Dewan Hsg.
GRUH Fin.
HDFC
HDFC Stand. Life
Indiabulls Hsg
L&T Fin.Holdings
LIC Hsg Fin
M&M Fin.
Muthoot Fin
1 Day (%)
-1.2
-0.4
0.2
-0.8
-0.1
-1.5
1.1
-2.7
-0.7
0.9
-0.6
0.6
-0.7
0.0
-3.0
0.2
-0.6
1.1
-0.7
-1.2
-2.2
-0.2
-0.3
-2.6
0.2
1.0
-0.1
0.7
-0.9
-2.1
-0.5
-2.5
-2.8
-2.9
-4.2
-0.3
-2.3
-1.7
-2.3
1.0
0.3
-1.2
-1.8
0.0
-0.1
-2.3
0.3
0.1
-0.1
-1.0
-0.6
1M (%)
1.1
14.0
-11.3
8.2
-4.1
-16.3
-0.9
11.8
1.5
-4.7
-4.1
-8.1
4.8
-5.6
-11.9
-6.0
0.4
-9.9
-10.9
-7.7
-3.2
-3.9
-5.7
-11.7
-7.8
-5.6
-8.1
-2.2
-3.9
-13.0
-10.7
-9.1
-26.3
-12.0
-10.5
-39.5
-14.1
-21.8
-6.5
-4.3
-7.9
9.1
-5.6
-6.8
-7.9
0.5
-8.7
-5.0
-4.7
-9.2
-11.2
12M (%)
-4.5
57.7
9.1
49.1
-13.1
33.7
17.0
87.3
91.8
-1.7
12.4
8.8
17.8
49.9
33.0
-17.4
59.3
Company
MAS Financial Serv.
PNB Housing
Repco Home
Shriram City Union
Shriram Trans.
Capital Goods
ABB
Bharat Elec.
BHEL
Blue Star
CG Cons. Elec.
CG Power & Inds Sol.
Cummins
GE T&D
Havells
K E C Intl
L&T
Siemens
Solar Ind
Thermax
Va Tech Wab.
Voltas
Cement
Ambuja Cem.
ACC
Birla Corp.
Dalmia Bharat
Grasim Inds.
India Cem
J K Cements
JK Lakshmi Ce
Ramco Cem
Orient Cem
Prism Cem
Sagar Cements
Sanghi Inds.
Shree Cem
Ultratech
Consumer
Asian Paints
Britannia
Colgate
Dabur
Emami
Godrej Cons.
GSK Cons.
HUL
ITC
Jyothy Lab
Marico
Nestle
Page Inds
Parag Milk
Pidilite Ind.
P&G Hygiene
1 Day (%)
-0.1
0.0
1.1
-0.6
0.3
-0.4
-0.7
0.8
1.7
0.4
-1.4
0.7
2.6
0.7
-1.5
-0.4
-0.9
-1.4
4.7
-0.3
1.5
0.1
0.5
0.4
4.2
1.2
-1.3
1.3
1.2
-1.3
0.0
0.2
-1.4
1.2
-0.4
-0.1
0.1
-0.9
1.7
0.1
0.0
0.8
1.6
0.7
-0.6
0.3
0.9
1.1
0.1
-0.8
-0.4
0.0
1M (%)
-6.6
-6.6
-8.4
-1.7
-2.9
-10.2
-5.3
-9.6
3.1
-7.9
-10.6
-11.2
-1.2
-2.6
17.3
-9.8
-12.4
-5.8
-5.7
-7.2
1.8
-4.5
-5.7
-23.5
-8.1
-1.6
-5.1
-9.2
4.0
-1.9
6.1
-6.1
-3.8
-5.7
-4.6
-5.5
-2.9
4.2
-6.0
-7.0
-5.3
2.8
1.6
-3.3
-4.3
-5.7
0.3
7.5
2.7
-1.3
-0.3
1.8
12M (%)
15.4
-12.2
6.2
44.6
23.7
11.1
-15.3
34.3
23.4
18.2
-9.0
40.7
24.7
143.9
33.5
-5.2
41.8
39.0
-5.9
63.8
10.5
15.8
30.5
45.2
39.0
-6.9
16.5
5.8
11.5
8.4
26.6
25.4
80.5
3.3
11.1
8.6
55.3
18.0
17.9
4.1
29.5
33.8
51.6
-1.9
-7.8
11.8
26.0
51.9
23.6
29.9
33.0
2.5
4.9
-17.3
7.0
35.1
20.3
-16.7
28.0
-9.4
32.9
1.2
24.9
10.3
-16.3
-12.3
-1.8
10.2
-29.2
-3.5
-30.3
54.2
2.3
49.3
61.7
43.4
29.4
44.7
40.0
-9.8
45.5
8.5
5 March 2018
26

MOSL Universe stock performance
Company
Prabhat Dairy
United Brew
United Spirits
Healthcare
Alembic Phar
Alkem Lab
Ajanta Pharma
Aurobindo
Biocon
Cadila
Cipla
Divis Lab
Dr Reddy’s
Fortis Health
Glenmark
Granules
GSK Pharma
IPCA Labs
Jubilant Life
Lupin
Laurus Labs
Sanofi India
Shilpa Medicare
Strides Shasun
Sun Pharma
Torrent Pharma
Infrastructure
Ashoka Buildcon
IRB Infra.Devl.
KNR Construct.
Sadbhav Engg.
Logistics
Allcargo Logistics
Concor
Gateway Distriparks
Media
Dish TV
D B Corp
Den Net.
Ent.Network
Hathway Cab.
Hind. Media
HT Media
Jagran Prak.
Music Broadcast
PVR
Prime Focus
Siti Net.
Sun TV
Zee Ent.
Metals
Hindalco
Hind. Zinc
JSPL
JSW Steel
1 Day (%)
-1.6
-0.5
-1.2
-0.3
-0.4
-0.1
1.7
-0.5
-0.3
-1.3
-0.6
-0.3
0.6
-0.1
-2.0
0.2
1.5
-4.9
-1.8
-1.1
-0.3
-0.3
-0.9
-0.2
-2.7
4.6
-1.6
-1.8
-0.6
-0.8
0.2
0.0
-3.2
-1.0
-2.8
0.6
-1.3
1.6
-0.9
0.7
0.3
-1.4
-0.1
-1.1
-1.2
-1.7
-2.0
-3.2
-2.0
-2.1
1M (%)
-19.8
-11.6
-2.0
0.4
-0.6
-0.6
1.8
1.3
-3.4
-0.8
-2.3
3.3
21.6
-7.7
-9.4
-2.9
20.9
-9.3
-6.8
2.9
2.3
-23.3
-5.1
-3.9
-1.7
-1.8
-7.2
-0.7
-3.2
-8.1
-5.3
-7.7
-7.6
0.9
-6.8
-0.1
-3.9
-4.7
-6.2
-1.3
1.6
-8.3
-6.0
-17.5
-9.4
-6.5
-6.5
2.6
-6.2
1.1
12M (%)
31.5
34.6
39.4
-3.6
3.7
-18.4
-8.1
68.4
-8.0
-0.9
32.8
-23.9
-17.5
-41.5
-13.4
-11.3
23.0
16.7
-45.3
3.9
19.6
-31.7
-39.2
-23.0
-2.5
27.2
-5.1
71.7
45.7
6.8
33.6
-16.1
-26.4
-11.4
21.3
-13.8
1.1
-10.5
7.6
-10.6
0.5
21.5
-51.0
26.9
9.6
27.0
-0.8
97.3
61.0
Company
Nalco
NMDC
Rain Industries
SAIL
Vedanta
Tata Steel
Oil & Gas
BPCL
GAIL
Gujarat Gas
Gujarat St. Pet.
HPCL
IOC
IGL
Mahanagar Gas
MRPL
Oil India
ONGC
PLNG
Reliance Ind.
Retail
Jubilant Food
PC Jeweller
Titan Co.
Technology
Cyient
HCL Tech.
Hexaware
Infosys
KPIT Tech
L&T Infotech
Mindtree
Mphasis
NIIT Tech
Persistent Sys
Tata Elxsi
TCS
Tech Mah
Wipro
Zensar Tech
Telecom
Bharti Airtel
Bharti Infratel
Idea Cellular
Tata Comm
Utiltites
Coal India
CESC
JSW Energy
NHPC Ltd
NTPC
Power Grid
Tata Power
1 Day (%)
-1.8
1.0
-5.0
-2.7
-1.9
0.5
3.0
-0.9
0.3
-2.4
-0.9
0.5
0.6
0.4
-1.3
-0.1
0.6
-2.4
-0.5
-1.2
-0.1
-0.7
-0.5
0.4
-0.5
-1.2
-0.4
-1.5
-0.4
-0.4
4.5
-2.1
-0.8
0.0
-0.2
-0.3
0.4
-0.1
-1.3
-0.8
-0.8
1.0
-1.7
-0.1
1.8
-0.2
-0.5
-0.5
1M (%)
-9.9
-7.8
-0.2
-9.4
-5.2
-3.0
-9.8
-6.8
2.8
1.0
-4.0
-8.5
1.1
3.9
-8.6
-1.9
-2.8
-4.2
0.4
-2.1
-31.2
-2.5
-1.1
-4.2
-9.3
1.4
3.3
9.5
7.7
-2.9
4.3
6.9
1.9
-3.2
0.1
-3.1
-6.0
-2.6
-1.0
-9.0
2.6
5.7
-3.6
-7.7
-4.5
-3.6
1.3
-6.0
12M (%)
-5.9
-13.0
308.3
27.8
21.8
43.2
0.6
19.1
31.1
29.5
9.0
-0.1
45.8
20.0
7.8
5.3
-2.2
20.5
53.6
100.2
77.8
85.1
32.2
11.1
51.9
13.2
55.4
99.4
72.2
44.6
109.5
30.9
39.8
22.5
22.6
19.6
-2.9
17.7
18.4
-26.7
-14.0
-2.6
21.5
24.3
-9.0
1.8
2.5
2.9
5 March 2018
27

MOSL Universe stock performance
Company
Others
Arvind
Avenue Super.
Bata India
BSE
Castrol India
Coromandel Intl
Delta Corp
Eveready Inds.
Interglobe
Indo Count
Info Edge
Kaveri Seed
Manpasand
MCX
Monsanto
Navneet Educat.
Oberoi Realty
PI Inds.
Piramal Enterp.
Quess Corp
SRF
S H Kelkar
Team Lease Serv.
Trident
UPL
V-Guard
1 Day (%)
-1.2
-2.5
-1.2
0.2
-0.1
-1.5
1.2
0.4
-0.4
-1.9
1.6
-1.2
3.3
-0.9
1.2
-1.3
-1.1
0.9
-1.5
-1.7
-0.2
1.9
-2.1
0.7
-2.0
-1.1
1M (%)
2.2
11.8
1.5
-8.1
9.7
0.9
-1.2
-5.1
9.1
-2.9
-2.6
-2.8
1.0
-1.1
-2.3
-8.3
-2.0
-3.1
-7.2
-0.7
4.8
-4.6
-12.0
-7.1
-5.8
3.5
12M (%)
9.2
42.4
-14.3
-1.7
66.3
129.6
58.7
52.7
-38.6
52.7
-0.7
5.7
-32.1
2.7
-9.9
49.9
7.0
39.3
56.2
22.3
-2.2
136.6
-2.0
-0.4
44.0
5 March 2018
28

THEMATIC/STRATEGY RESEARCH GALLERY

REPORT GALLERY
RECENT INITIATING COVERAGE REPORTS
Rs

DIFFERENTIATED PRODUCT GALLERY

Explanation of Investment Rating
Investment Rating
BUY
SELL
NEUTRAL
UNDER REVIEW
NOT RATED
Expected return (over 12-month)
>=15%
< - 10%
> - 10 % to 15%
Rating may undergo a change
We have forward looking estimates for the stock but we refrain from assigning recommendation
*In case the recommendation given by the Research Analyst becomes inconsistent with the investment rating legend, the Research Analyst shall within 28 days of the inconsistency, take appropriate measures to make the recommendation consistent with the investment rating legend.
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services,
Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of
which are available on
www.motilaloswal.com.
MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited
(BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association of
Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at
http://onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
Regulatory Enquiries against Motilal Oswal Securities Limited by SEBI:
SEBI pursuant to a complaint from client Shri C.R. Mohanraj alleging unauthorized trading, issued a letter dated 29th April 2014 to MOSL notifying appointment of an Adjudicating Officer as per SEBI regulations to hold inquiry and
adjudge violation of SEBI Regulations; MOSL requested SEBI to provide all documents, records, investigation report relied upon by SEBI which were referred in Show Cause Notice. The matter is closed and MOSL had to pay Rs. 2
lakhs towards penalty for misplacement of original POA of client.
MOSL, it’s associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at
the end of the month immediately preceding the date of publication of the Research Report.
MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act
as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial
instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.;
however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there
might exist an inherent conflict of interest in some of the stocks mentioned in the research report.
Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have
received any compensation from the subject company in the past 12 months.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have:
a)
managed or co-managed public offering of securities from subject company of this research report,
b)
received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c)
received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d)
Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report.
MOSL and it’s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in
this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result,
the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or
brokerage service transactions.
Terms & Conditions:
This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part
or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report
is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied,
is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to
buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by
virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the
specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement
Analyst ownership of the stock
Companies where there is interest
No
A graph of daily closing prices of securities is available at
www.nseindia.com, www.bseindia.com.
Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or
its associates maintains arm’s length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have
expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject
MOSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities
and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) “SFO”. As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong)
Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to “Professional Investors” as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only
available to professional investor and will be engaged only with professional investors.” Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from
registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered
investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption
under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional
Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional
investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule
15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S.,
MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of
this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject
to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal
Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the
Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited:
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced
in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial
instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in
this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of
independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document
(including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including
those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy,
completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the
views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval.
MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform
investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this
into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and
the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or
published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such
distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all
jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall
be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information.
The person accessing this information specifically agrees
to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL
or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm
Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id:
na@motilaloswal.com,
Contact No.:022-30801085.
Registration details of group entities.: MOSL: SEBI Registration: INZ000158836 (BSE/NSE/MSE); CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA000007100.
Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth
management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real
Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products
13 December 2016
30